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 I 
Histomorphological and immunohistochemical characterization of different fat 
depots of dairy cows during early lactation 
 
Early lactation is attended by massive fat mobilization, decreased insulin sensitivity and 
immunosuppression. The aim of this dissertation was to study the effects of lactation 
and conjugated linoleic acid (CLA) on adipocyte size and on the invasion of phagocytic 
immune cells in different fat depots of dairy cows during the first 105 days in milk 
(DIM). The present study focused on two aspects: First, mean adipocyte areas (µm²) of 
different subcutaneous (SC) and visceral (VC) fat depots were assessed to investigate 
the effects of CLA on adipocyte size, with regards to the changes during early lactation. 
Second, adipose tissue (AT) sections were immunohistochemically stained to 
characterize different fat depots of early-lactating dairy cows in terms of phagocytic 
immune cell present. In addition, the changes in the portion of phagocytic immune cells 
in AT of early-lactating cows were compared with non-pregnant, over-conditioned 
heifers. The timely changes of adipocyte size were non-uniform in different SC and VC 
fat depots: retroperitoneal adipocyte sizes were significantly smaller at 105 DIM 
compared to 1 DIM, whereas SC adipocytes remained unchanged. When comparing the 
control and CLA group, adipocyte sizes were smaller both in SC and in VC fat depots to 
different extent in CLA supplemented cows. Immunohistochemical analyses of different 
fat depots revealed a low incidence of phagocytic immune cell infiltration in early-
lactating cows. The average portion of macrophages in a few positive AT samples was 
slightly lower in SC versus VC depots. No significant alterations in this infiltration 
phenomenon, with regards to DIM and CLA supplementation were observed during 
early lactation. Moreover, increased accumulation of phagocytic immune cells in the SC 
fat of non-pregnant, over-conditioned heifers might be related to large adipocytes, 
secreting higher amounts of chemoattractant adipokines. In conclusion, dietary CLA 
supplements have site-specific effects on adipocyte size of different fat depots in dairy 
cows. CLA-induced decreases in adipocyte size indicate lipolytic and/or antilipogenic 
effects of CLA on AT. Moreover, early-lactating cows are not ‘obese’ and may thus 
lack significant infiltration of phagocytic cells into AT and therefore, these immune 
cells might have no major role in the immunologic and metabolic adaptations during 
early lactation. The results are of general importance to Animal Science and provide a 
general basis for understanding CLA effects on body fat depots in dairy cattle.  
 II 
Histomorphologische und immunhistochemische Charakterisierung verschiedener 
Fettdepots von Milchkühen während der frühen Laktation 
 
Während der Fühlaktation kommt es zu einer massiven Fettmobilisierung, verringerter 
Insulinsensitivität und Immunsuppression. Das Ziel dieser Dissertation war es, den 
Einfluss konjugierter Linolsäuren (CLA) auf die Adipozytengröße (µm2) sowie die 
Einwanderung phagozytierender Immunzellen in subkutane (SC) und viszerale (VC) 
Fettdepots bei Milchkühen während der ersten 105 Laktationstage zu untersuchen. 
Zusätzlich zum immunhistochemischen Nachweis der Immunzellen bei 
frühlaktierenden Kühen, wurde die Anzahl phagozytierenden Zellen im Fettgewebe von 
nicht tragenden, überkonditionierten Färsen untersucht und verglichen. Die  
Adipozytengröße variierten in den verschiedenen SC und VC Fettdepots: An Tag 105 
der Laktation war die Adipozytengröße im retroperitonealen Fett signifikant geringer, 
als an Tag 1 der Laktation, wobei die Adipozyten im SC Fett unverändert blieben. Beim 
Vergleich zwischen Kontroll- und CLA-Supplementationsgruppe waren die Adipozyten 
sowohl in den SC als auch in den VC Fettdepots der CLA Tiere kleiner. Die 
immunhistochemischen Färbungen zeigten eine geringfügige Infiltration 
phaygozytierender Immunzellen bei frühlaktierenden Kühen in allen untersuchten 
Fettdepots. In den wenigen positiven Fettproben war die Anzahl von Makrophagen in 
SC niedriger als in VC Fettdepots. Bezüglich Laktationsverlauf und CLA 
Supplementation konnten keine signifikanten Veränderungen festgestellt werden. Eine 
erhöhte Anreicherung phagozytierender Immunzellen im SC Fett von nicht tragenden 
überkonditionierten Färsen könnte mit der Anzahl großer Adipozyten im 
Zusammenhang stehen, da diese mehr Chemokine freisetzen. Die CLA-
Supplementation zeigt somit gewebespezifische Effekte auf die Adipozytengröße von 
Milchkühen, die auf lipolytische oder antilipogene Effekte der CLA im Fettgewebe 
zurückgeführt werden. Zudem sind frühlaktierende Kühe nicht „übergewichtig“ und 
weisen daher wahrscheinlich eine geringere Infiltration phagozytierender Zellen ins 
Fettgewebe auf, weshalb diese Immunzellen offenbar keine große Rolle in der 
immunologischen und metabolischen Adaptation während der frühen Laktation spielen. 
Die Ergebnisse sind von allgemeiner Bedeutung für die Nutztierwissenschaften und 
liefern grundlegende Erkenntnisse für das Verständnis von CLA-Effekten auf das 
Körperfett bei Milchkühen.   
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Introduction 1
1 Introduction 
 
1.1 Metabolic stress in dairy cows during early lactation  
 
Most dairy cows, especially high-yielding breeds, are susceptible to metabolic disorders 
during early lactation. The cows in this period undergo a situation of compromised 
immune response which predispose to infectious diseases like mastitis, metritis, and 
laminitis (Heuer et al., 1999; Collard et al., 2000). Dairy cows presenting such 
disturbances in early lactation cause economic losses (Drackley, 1999). Moreover, 
metabolic disorders during early lactation are related to decreased fertility (Butler and 
Smith, 1989). Although most cows overcome this period without showing signs of 
clinical disease, the dairy industry loses thousands of cows each year for culling due to 
metabolic or infectious diseases, and thus encounters increasing replacement costs. Dry 
matter (DM) intake of dairy cows is low in early lactation, whereas energy demand for 
milk production is high, which leads to cows being in negative energy balance (NEB). 
Therefore, energy has to be mobilized from body reserves, mainly from the adipose 
tissue (AT) to support milk production and animal body maintenance. High-yielding 
dairy cows lose approx. 60% or more of their body fat in the first weeks after parturition 
(Knop and Cernescu, 2009). Extreme fat mobilization from AT results in increased 
circulating concentrations of nonesterified fatty acids (NEFA) and ß-hydroxybutyrate 
(BHBA) that may result in metabolic disorders like fatty liver and ketosis (Herdt, 2000).  
 
1.2 Adipose tissue 
 
1.2.1    Adipose tissue function   
  
Adipose tissue is a highly specialized connective tissue dealing mainly with processes 
for storage and release of energy. According to its diverse biochemical and functional 
characteristics, it is classified into two distinct types: white AT (WAT) and brown AT. 
In the present study the focus lies on WAT, since it is the most abundant one and 
quantitatively plays the most important role in adults (Marra and Bertolani, 2009).  
Introduction 2
 
 
Fig. 1: Schematic representation of the multiple adipose-derived factors.  
                        Abbreviations: MT, metallothionein; SAA, serum amyloid A; TNF-α, 
tumor necrosis factor-alpha; IL, interleukin; MIF, macrophage  
migratory inhibitory factor;  MCP-1,  monocyte chemoattractant protein-
1; RANTES, regulated upon activation, normally T-expressed, and 
presumably secreted; SDF-1α, stromal cell-derived factor 1 alpha; TF, 
tissue factor; PAI-1, plasminogen activator inhibitor-1; TGF-ß, 
transforming growth factor-beta; VEGF, vascular endothelial growth 
factor; IGF-1, insulin-like growth factor-1; NGF, nerve growth factor; 
LPL, lipoprotein lipase; ZAG, zinc-α2-glycoprotein; PG, prostaglandin 
(modified from Bing and Trayhurn, 2009; Skurk et al., 2009). 
 
 
White AT stores and releases energy in the form of triacylglycerides (TAG) and plays 
an important role in the regulation and maintenance of energy homeostasis. During 
periods of fuel surplus, glucose and fatty acids (FA) are taken up by adipocytes and 
converted into TAG for storage. The term lipogenesis encompasses the processes of FA 
and subsequent TAG synthesis. During periods of fuel deprivation, the TAG are broken 
down in the adipocytes into FA and glycerol and then released into the circulation; this 
process is termed lipolysis (Boschmann, 2001). Two key enzymes: lipoprotein lipase 
(LPL; located extracellularly) and hormone sensitive lipase (HSL; located 
intracellularly) are involved in the regulation of lipogenesis and lipolysis, respectively. 
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White AT also serves as a cushion for various organs and is necessary for mechanical 
and thermal insulation (Klaus, 2001).  
Since the discovery of leptin in 1994, it has been recognized that adipocytes produce 
and secrete a wide range of molecules, collectively termed as adipokines (Fig. 1). Thus, 
WAT has been accepted as an important endocrine and secretory organ (Ahima, 2006). 
The adipokines are involved in a wide range of physiological and metabolic processes 
including appetite regulation, glucose metabolism, insulin sensitivity, lipid metabolism, 
inflammation, and immune functions (Frühbeck, 2008). Numerous proinflammatory, 
antiinflammatory, immunomodulating proteins and peptides (in excess of 100) that 
belong to the cytokine, chemokine, complement, and growth factor families have been 
identified in adipocytes, which points to a role of WAT in the innate immune system 
(Pattrick et al., 2009). At the same time, WAT expresses receptors for most of these 
factors, which warrant an extensive crosstalk at a local and systemic  level  in  response  
to  specific  external  stimuli  or  metabolic  changes (Frühbeck, 2008). Moreover, WAT 
undergoes macroscopic changes, such as hypertrophy, stiffness, neovascularization and 
changes of cellular composition, such as monocytic infiltration, alterations of adipocyte 
size, and changes in the ratio of preadipocytes to mature adipocytes (plasticity of the 
WAT) and is directly involved in inflammatory processes (Schäffler and Schölmerich, 
2010). 
 
1.2.2    Morphology of white adipose tissue 
 
At the cellular level, WAT is a heterogeneous tissue containing mature adipocytes and 
the stromal-vascular fraction (SVF). Mature adipocytes represent about 50% of the total 
cell content of WAT (Hausman, 1985) and store the TAG which in turn constitute up to 
85% of tissue weight (Trayhurn et al., 2006). The remaining SVF consists of many cell 
types, including preadipocytes, fibroblasts, pericytes, blood and endothelial cells, 
diverse precursor cells and immune cells, such as macrophages and T-lymphocytes. The 
multicellularity of WAT is involved in autocrine, paracrine, and endocrine processes 
and crosstalks (Hauner, 2005); however, their differential contribution to the total pool 
of adipokines is not well clarified (Weisberg et al., 2003; Fain et al., 2004; Antuna-
Puente et al., 2008; Fain et al., 2008). 
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White AT is not a single homogeneous compartment; rather it displays depot and sex-
specific metabolic properties and is subject to differential neural and endocrine 
regulation (Ross et al., 1996; Mack, 2011). White AT depots are distributed throughout 
the body and can be roughly categorized as subcutaneous (SC) and visceral (VC) depots 
(Shen et al., 2003). Some other non-visceral WAT depots include: inter-, intra-, and 
perimuscular AT (Frühbeck, 2008). Small quantities can also be found within and 
around many organs and blood vessels (Cinti, 2005). The SC depot comprises the fat 
layer found between the dermis and the aponeuroses and fasciae of the muscles 
(Frühbeck, 2008). Shen et al. (2003) proposed a classification for the VC depots, 
consisting of the AT distributed in three body cavities, such as intrathoracic (e.g., extra- 
and intrapericardial), intraabdominal (e.g., omental, mesenteric, and retroperitoneal), 
and intrapelvic (e.g., gonadal and urogenital).  
There is mounting evidence that WAT is distinct both in cellular makeup and size, as 
well as vasculature content and lymphatic profusion (Wright-Piekarski, 2010). White 
AT depots are shown to have varying metabolic functions. When comparing the 
omental and SC depots in humans, the omental depot has a greater effect on overall 
metabolism (O'Rourke, 2009). It has been suggested that the effect may be due to any of 
the following: its vascular proximity to the liver (portal theory), by higher production of 
adipokines and cytokines (Wajchenberg et al., 2002), or by its method of expansion: 
hyperplasia vs. hypertrophy (Joe et al., 2009). The portal theory suggests that the 
proximity of VC depots to the liver, combined with its higher lipolytic rate compared 
with SC depots, leads to an increase in free FA being delivered to the liver, which in 
turn contributes to liver insulin resistance (Kabir et al., 2005). 
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Fig. 2: Morphology of typical mature adipocytes (modified from 
www.Adamimages.com) 
 
Within the WAT, unilocular adipocytes are individually held in place by delicate 
reticular fibers clustering in lobules bounded by fibrous septa. It is highly vascularized 
and innervated by the sympathetic (Cinti, 2001) and the parasympathetic (Kreier and 
Buijs, 2007) nervous system. Mature adipocytes contain a single, large lipid inclusion 
surrounded by a thin layer of cytoplasm. The lipid mass compresses the flattened 
nucleus to an eccentric position, producing a signet-ring appearance (Fig. 2). 
Mitochondria present in the thicker portion of the cytoplasmic rim, near the nucleus. 
The characteristic spherical form of adipocytes varies enormously in size, ranging from 
20 to 200 µm in diameter in humans which is due to the ability of the cells to 
accumulate different amounts of TAG in a single vacuole (Frühbeck, 2008). 
  
1.2.3    Growth of white adipose tissue 
  
White AT growth requires continuous remodeling of the vascular network, mainly the 
microvasculature, which is then subject to neovascularization and/or remodeling of 
existing capillaries (Christiaens and Lijnen, 2009). In the past, it was believed that the 
number of adipocytes does not increase after birth. According to the report of Schling 
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and Löffler (2002), WAT can increase either due to hypertrophy of existing adipocytes 
or hyperplasia where the number of adipocytes is increased. The determining factors of 
AT mass in adults are not completely understood; however, increased lipid storage in 
fully differentiated mature adipocytes, resulting in hypertrophied adipocytes appears to 
be the most important (Bjorntorp, 1974; Hirsch and Batchelor, 1976). In contrast, 
hyperplasia and the determination of adipocyte number appear to occur during 
childhood (Knittle et al., 1979; Spalding et al., 2008). Moreover, the number of 
adipocyte remains constant in adulthood in lean and obese individuals, even after 
marked weight loss which had been stable for two years at the time of the measurements 
(Spalding et al., 2008). Nevertheless, if it comes to massive increases in body weight 
(BW) and adipocytes have reached a critical size, hyperplasia also appears to occur 
(Hirsch and Batchelor, 1976), which is achieved by inducing adipogenesis. 
Adipogenesis also takes place in normal weight individuals since WAT is a plastic 
organ with an annual turnover of adipocytes of approx. 10% (Spalding et al., 2008).   
 
1.2.4 Adipogenesis 
 
Adipogenesis refers to the process of development of fat cells from preadipocytes to 
mature adipocytes that are capable of metabolizing lipid (lipogenesis and lipolysis). The 
two main steps involved in adipogenesis are proliferation and differentiation of the 
progenitor fat cells (Fig. 3). The adipose cell lineage originates from multipotent 
mesenchymal stem cells that develop into adipoblasts. These adipoblasts gives rise to 
preadipocytes that proliferate to expand the cell population. Differentiation is the 
transition from undifferentiated fibroblast-like preadipocytes into mature round lipid-
filled fat cells (Butterwith, 1994). Proliferating preadipocytes undergo growth arrest 
initiated through contact inhibition. Following growth arrest, preadipocytes must 
receive an appropriate combination of mitogenic and adipogenic signals to continue 
through the subsequent differentiation steps, leading to the progressive acquisition of 
the morphological and biochemical characteristics of mature adipocytes (Gregoire, 
2001).  
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Fig. 3: Schematic representation of the major processes of adipogenesis. 
Deriving from mesenchymal stem cells, preadipocytes represent a cell 
group of the stromal-vascular fraction in the adipose tissue. After 
hormonal stimulation, preadipocytes proliferate (in vitro until 
confluency) before the process of differentiation can be induced. During 
differentiation, the cells collect lipid droplets until they become all lipid-
filled mature adipocytes (modified from Gummersbach, 2008).  
 
 
Adipogenesis is regulated by the hormonally induced coordinated expression and 
activation of two main groups of transcription factors, the CCAAT/enhancer binding 
protein (C/EBP) and peroxisome proliferator-activated receptor (PPAR)-γ (Rosen et al., 
2002). Some of the key features of adipogenic differentiation can be summarized as 
follows: At early differentiation, C/EBP-β and δ are expressed and increase the 
expression of PPAR-γ2. PPAR-γ2 heterodimerizes with retinoic X receptors (RXR) and 
activates C/EBP-α which exerts positive feedback on PPAR-γ2 until both transcription 
factors reach maximum levels as differentiation proceeds. Additionally, sterol 
responsive element binding protein-1, also called adipocyte determination and 
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differentiation factor-1 (ADD1/SREBP-1) can increase the transcriptional activity of 
PPAR-γ, while Forkhead box C2 can enhance the activity of C/EBP-α, PPAR-γ, and 
ADD1/SREBP-1 (Gregoire et al., 1998; Rosen and Spiegelman, 2000; Gregoire, 2001; 
Valet et al., 2002; Farmer, 2006).   
 
1.2.5 Immune cell infiltration in white adipose tissue 
 
Many cell types can infiltrate into WAT, including immune cells such as T-lymphocytes 
and macrophages with their number being increased in obese mice (Weisberg et al., 
2003; Xu et al., 2003) and humans (Cancello et al., 2006; Curat et al., 2006). It has been 
suggested that especially the adipose tissue macrophages (ATM) induce local and 
systemic insulin resistance by promoting a proinflammatory micromilieu (Surmi and 
Hasty, 2008). As yet, it is neither clear what initiates the increased immune cell 
infiltration nor the sequence in which the different immune cell types appear in WAT. 
Severe hypertrophy of adipocytes, being mostly connected with FA flux, hypoxia, 
adipocyte cell death, increased leptin secretion, and endothelial dysfunction may be all 
contributing factors for immune cell infiltration into WAT (Surmi and Hasty, 2008).  
There is evidence that recruitment of neutrophils occurs before monocyte infiltration 
into WAT (Elgazar-Carmon et al., 2008). However, the number of T-lymphocytes in 
WAT correlates with the waist circumference of type 2 diabetes patients. Additionally, 
it was shown in a mouse model of high-fat diet induced obesity that T-lymphocyte 
infiltration precedes the accumulation of macrophages in WAT, during the development 
of insulin resistance (Kintscher et al., 2008).  
Monocytes infiltrate the tissue and differentiate to macrophages producing further 
cytokines such as TNF-α and IL-1 (Mosser, 2003), which are very potent 
proinflammatory activators of endothelial cells (Petzelbauer et al., 1993), adipocytes 
(Wang and Trayhurn, 2006), and other cell types. Additionally, an in vitro co-culture 
study of macrophages and adipocytes showed that the TNF-α, released from 
macrophages, interferes with adipocyte insulin signaling and induces lipolysis 
(Suganami et al., 2005). These mechanisms altogether may result in a positive feedback 
loop and are shown in Fig. 4. 
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Fig. 4: Monocyte infiltration into white adipose tissue.  
I: Some adipokines (e.g., TNF-α) are able to activate the endothelium. 
This is characterized by the expression of selectins and adhesion 
molecules such as intercellular adhesion molecule 1 (ICAM-1) and 
vascular cell adhesion molecule 1 (VCAM-1) and the release of 
chemokines from the endothelial cells. II: Activated monocytes and 
other immune cells adhere to the adhesion proteins on the endothelium 
via integrins which is followed by transmigration. III: After the 
diapedesis the monocytes differentiate into macrophages. Activated 
macrophages release large amounts of TNF-α and IL-1 and several 
chemokines. IV: The released cytokines from macrophages activate the 
endothelium itself and trigger the adipocytes and preadipocytes to 
change their secretion to a more inflammatory pattern. Abbreviations: 
CAMs, cellular adhesion molecules; EC, endothelial cells; IL, 
interleukin; MCP-1, monocyte chemoattractant protein-1; MIP-1α, 
macrophage inflammatory protein-1 alpha; RANTES, regulated  upon 
activation, normally T-expressed, and presumably secreted; SDF-1α, 
stromal cell-derived factor-1 alpha; TNFα, tumor necrosis factor-alpha 
(modified from Mack, 2011). 
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Monocyte recruitment may be initiated by an activated endothelium, adipocytes, 
preadipocytes, and other cells residing in WAT, producing chemoattractants such as 
MCP-1 and IL-8 (Fain et al., 2004; Fain and Madan, 2005). Macrophages can be 
distinguished in M1-classically activated and M2-alternatively activated 
subpopulations, as well as intermediate types having both M1 and M2 characteristics 
and are found in WAT (Lumeng et al., 2007; Zeyda et al., 2007; Bourlier et al., 2008). 
M1 macrophages are induced by inflammatory agents, have phagocytic activity, 
predominantly secrete proinflammatory cytokines and are important in the initiation of 
inflammation. M2 macrophages are induced by IL-4 and IL-13 and secrete 
predominantly antiinflammatory cytokines having a reparative and remodeling function 
by promoting the formation of new blood vessels and are important in terminating 
inflammatory process (Mosser, 2003; Bourlier et al., 2008). So far, most research on 
ATM infiltration has focused on their contribution to the development of obesity-
associated pathologies through systemic effects in nonruminant species (Bouloumié et 
al., 2005; Schäffler and Schölmerich, 2010). In contrast to nonruminants, no report 
exists about immune cell infiltration into bovine AT. 
 
1.3 Conjugated linoleic acid 
 
1.3.1 Structure and origins  
 
Conjugated linoleic acid (CLA) designates a group of unsaturated FA with two 
conjugated double bonds that are found naturally in milk and meat of ruminants. They 
were first discovered by Pariza and his group when investigating the carcinogenic 
components of grilled beef (Pariza and Hargraves, 1985). These modified FA are 
formed by the biological or industrial hydrogenation of linoleic acid (18:2, n-6), and 
were surprisingly found to have anticancer rather than procancer properties. The term 
CLA describes a group of positional and geometric isomers of linoleic acid, where one 
or both of the double bonds are either in the cis or the trans configuration and trans-
posed to different positions along the acyl chain with the bonds separated by a simple 
carbon-carbon linkage rather than by the normal methylene group (-CH2-).  
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Fig. 5: Structure of the linoleic acid and its two main conjugated derivatives  
 
The structure of the cis-9, trans-11 (c9,t11) and the trans-10, cis-12 (t10,c12) isomers of 
CLA, compared to their natural homologue linoleic acid are shown in Fig. 5. A number 
of cis-cis, cis-trans, trans-cis and trans-trans isomers with the double bonds at various 
locations along the acyl chain, from carbon-6 to carbon-15, have been identified by 
various chemical reductive, chromatographic, and spectroscopic techniques (Adlof, 
2003; Christie, 2003; Dobson, 2003). 
The major natural sources of CLA are the body tissues, predominantly the AT, of 
ruminants. Ruminant meat, particularly the fat associated with meat, is an important 
dietary source of CLA, contributing in the region of 25 to 30% of the total intake in 
Western populations (McGuire et al., 1999; Parodi, 2003). Milk, yogurt, cheese, and 
butter are also an excellent dietary source of CLA. The proportion of CLA ranges from 
0.34 to 1.07% of the total fat in dairy products, and from 0.12 to 0.68% of the total fat 
in raw or processed beef products (Dhiman et al., 2005; Silveira et al., 2007; Mendis et 
al., 2008). The CLA content of food is dependent on several factors including the 
season and the animal’s breed, nutritional status, and age (Dhiman et al., 2005).  
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Fig. 6: Biosynthesis of CLA and its incorporation into milk and meat of 
ruminants (modified from Griinari and Bauman, 1999) 
 
The rumen of ruminants is likened to a large anaerobic fermentation vat which contains 
microbes capable of biohydrogenating the ingested polyunsaturated FA (PUFA), 
derived largely from forage but also from other feed sources (e.g., added grain or fish 
oils). The first step in the biohydrogenation of dietary linoleic acid results in the 
formation of the c9,t11 isomer, due to isomerization and transposition of the delta-12 
double bond. This is the most abundant natural isomer present in ruminant AT (over 
90% of total CLA) and has been termed rumenic acid (McGuire et al., 1999; Parodi, 
2003). Kepler and Tove (1967) extracted a linoleate isomerase from the rumen bacteria 
(Butyrivibrio fibrisolvens) which is responsible for the isomerization of linoleic acid 
into RA in the first step. Further hydrogenation of rumenic acid results in the production 
of trans-11-18:1 vaccenic acid, which is the major trans-monounsaturated FA present in 
the fats of ruminant food products (McGuire et al., 1999; Parodi, 2003). The pathways 
for the biosynthesis of CLA and its incorporation into milk and meat of ruminants are 
shown in Fig. 6.  
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1.3.2  Effective isomers and general health claims  
 
Many CLA isomers exist and the biological properties can differ among CLA isomers. 
The predominant isomer in naturally occurring foods is the c9,t11, with minor but 
significant proportions of the t10,c12 (McGuire et al., 1999; Parodi, 2003). Although 
several other isoforms of CLA have been identified (i.e., t9,t11; c9,c11; t10,t11; and 
c10,c12), the c9,t11 and t10,c12 isomers appear to be the most biologically active 
(Wallace et al., 2007). The c9,t11 isomer comprises approx. 90% of CLA found in 
ruminant meats and dairy products and the t10,c12 isomer comprises the remaining 
10%. This contrasts with commercial preparations of CLA where proportions of the two 
main isomers are usually equal, although the chemical method for synthesis will allow a 
variety of ratios for the two isomers in the final mixture (McGuire et al., 1999; Parodi, 
2003).  
The growing interest in CLA research over the past three decades attributed to 
identification of numerous beneficial health effects in various animal models and in 
cultures of various types of animal and human cells. Potential beneficial health effects 
of CLA include its anticarcinogenic, antiatherogenic, antiobesity, antidiabetogenic, and 
antiinflammatory properties. Dietary CLA also have reported to exert beneficial 
regulatory effects on immune function, lipid and eicosanoid metabolism, cytokine and 
immunoglobulin production, and can modulate the expression of a number of genes, 
either directly or through specific transcription factors involved in the many metabolic 
processes they affect (Nicolosi et al., 1997; Park et al., 1997; Cook and Pariza, 1998). 
Dietary CLA supplementation has been reported to change body composition by 
reducing fat to lean body mass ratio in several experimental animals including mice 
(Park et al., 1997; DeLany et al., 1999; Park et al., 1999), pigs (Ostrowska et al., 1999), 
rats and chickens (Pariza et al., 1996), also in obese humans (Blankson et al., 2000). 
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1.3.3 Spectrum of activity and mechanisms of action of CLA in monogastric 
species 
 
 
Regarding the fat-decreasing effect, there is much evidence showing that CLA 
decreases preadipocyte differentiation in animal (Brodie et al., 1999; Kang et al., 2003) 
and human (Brown et al., 2003) preadipocytes. This finding is in contrast to another 
study that has found no significant effect of CLA on the expression of key transcription 
factors of adipogenesis (Choi et al., 2000). One of the mechanisms proposed to explain 
the effect of CLA on AT mass is via the PPAR. The PPAR are ligand-activated nuclear 
hormone receptors that control the expression of genes involved in cellular metabolism 
and differentiation (Spiegelman, 1998; Desvergne and Wahli, 1999). Both c9,t11 and 
t10,c12 are potent ligands of PPAR-α and -δ, with PPAR-α showing the highest affinity 
(Moya-Camarena et al., 1999). It has been suggested that increased β-oxidation and 
energy expenditure due to activation of PPAR-α may contribute to the antiadipogenic 
effect of the t10,c12 isomer (Sakono et al., 1999; Delany and West, 2000). Conversely, 
one study using PPARα- knock-out mice demonstrated that the effect of CLA on body 
composition is independent of PPARα activation (Peters et al., 2001). Brown et al. 
(2003) reported that the t10,c12, but not the c9,t11 isomer of CLA decreases glucose 
and FA uptake and oxidation. Moreover, the t10,c12 isomer decreases preadipocyte 
differentiation by decreasing PPAR-γ expression (Hargrave et al., 2002; Brown and 
McIntosh, 2003; Brown et al., 2003), whereas the c9,t11 isomer increases the 
expression of PPAR-γ.  
Regarding the effects of CLA on adipokine secretion, the c9,t11 and t10,c12 isomers 
seem to have opposing effects. The t10,c12 isomer promotes ATM infiltration and 
decreases leptin and adiponectin secretion, which in turn contributes to insulin 
resistance and hyperinsulinemia in CLA fed animals and humans (Clément et al., 2002; 
Poirier et al., 2006; Pérez-Matute et al., 2007). CLA-induced shifts in the expression of 
these adipokines are therefore important both for metabolism and immune function. The 
t10,c12 isomer rapidly induces inflammatory factors, such as TNF-α and IL-6 gene  
expression in WAT (Ahn et al., 2006; Poirier et al., 2006). In vitro studies with 3T3-L1 
and human adipocytes have also shown that the t10,c12 isomer directly stimulates the 
IL-6 secretion (Chung et al., 2005; Poirier et al., 2006). In contrast, the c9,t11 isomer 
improves insulin and glucose metabolism. Supplementation with c9,t11 isomer results 
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in low ATM infiltration with concomitant decrease in inflammatory cytokines, which 
may improve insulin sensitivity (Moloney et al., 2007).  
In addition to the initial health benefits, CLA supplementation has also been reported to 
be associated with some deleterious effects both in mice and humans (Tsuboyama-
Kasaoka et al., 2000; Riserus et al., 2004). Supplementation with CLA induced insulin 
resistance, stable hyperinsulinemia, and fatty liver (West et al., 1998; Delany et al., 
1999; Tsuboyama-Kasaoka et al., 2000; Clément et al., 2002). These effects are entirely 
attributable to the t10,c12 isomer (Clément et al., 2002), but are also observed when 
using commercial CLA mixture (West et al., 1998). These effects might be the negative 
consequences of increased energy expenditure, fecal energy loss, apoptosis, FA 
oxidation, and lipolysis as well as decreased preadipocyte differentiation and 
lipogenesis (Wang and Jones, 2004).  
 
1.3.4 Use of CLA in dairy cows 
 
The  use  of  CLA  as  a supplement  to  dairy  cows  was  initially  conceived  to 
increase its content in milk for the benefit of consumer health. The findings of Loor and 
Herbein (1998) and Chouinard et al. (1999) with abomasal infusion studies 
demonstrated that CLA supplements decreased milk fat yield by inhibiting de novo 
lipogenesis in the mammary gland. Subsequent work in lactating dairy cows by 
Baumgard et al. (2000) demonstrated that the isomer involved in that effect was the 
t10,c12 isomer, albeit the c9,t11 isomer had less effect  (Perfield II et al., 2007). These 
findings are also consistent with other studies in nursing women (Masters et al., 2002) 
and lactating rats (Ringseis et al., 2004). These results suggested a great potential for the 
use of CLA supplement as a tool to manipulate milk composition. The milk fat-
decreasing effects of CLA have been also reported in other supplementation trials 
(Giesy et al., 2002; Perfield II et al., 2002; Bernal-Santos et al., 2003; von Soosten et 
al., 2011). Those studies were done with high-yielding cows and demonstrated 
decreased milk fat content but variable results regarding milk and protein yield. The 
high-yielding dairy cows are challenged to meet its nutritional requirements, 
particularly in early lactation. Thus, inhibition of milk fat excretion may have favored 
positive responses in milk and milk protein production (Mackle et al., 2003; de Veth et 
al., 2006; Kay et al., 2007). This could be beneficial for saving energy to counteract the 
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physiological NEB in early-lactating dairy cows. However, CLA supplementation 
seems to leave body fat mostly unaffected in dairy cows because body condition score 
(BCS), NEFA, and plasma leptin concentrations are not different in CLA supplemented 
cows versus control group (Baumgard et al., 2002; Kay et al., 2006).  
In contrast to the studies in monogastric species, no reports exist about body fat-
decreasing effects of CLA in ruminants. Also reports about immune cell infiltration into 
bovine AT, in particular addressing the heterogeneity of the SC versus VC depots are 
lacking. Herein, we hypothesized that dietary supplementation of CLA has site-specific 
effects on adipocyte size of different fat depots in dairy cows during early lactation. It 
was also hypothesized that phagocytic immune cell infiltration in bovine AT is 
independent of immunologic and metabolic adaptations during early lactation. 
Therefore, the present research study has been designed with the following objectives: 
1) To characterize different SC and VC fat depots of dairy cows in terms of adipocyte 
size during early lactation, 
2) To investigate phagocytic immune cell infiltration in bovine AT, 
3) To evaluate the effects of CLA on adipocyte size of different fat depots of dairy cows 
during the first 105 DIM, and  
4) To investigate the potential effects of CLA on the invasion of phagocytic immune 
cells into WAT of dairy cows.  
 
The goal of the aforementioned approaches was to improve the knowledge about the 
effects of long-term dietary CLA supplementation on body fat depots of dairy cows, 
with regards to the changes during early lactation. The results are of general importance 
to Animal Science and provide a general basis for the regulatory role of AT in 
ruminants. 
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Abstract 
 
The aim of this study was to investigate the effects of lactation and conjugated linoleic 
acid (CLA) supplementation on adipocyte sizes of subcutaneous (SC) and visceral (VC) 
fat depots in primiparous dairy cows during the first 105 days in milk (DIM). German 
Holstein-Friesian cows (n = 25) were divided into a control (CON) and a CLA group. 
From the first DIM until sample collection, CLA cows were fed 100 g of CLA 
supplement/d (about 6% of c9,t11 and t10,c12 isomers each), whereas the CON cows 
received 100 g/d of a fatty acid mixture instead of CLA. The CON cows (n = 5 each) 
were slaughtered at 1, 42, and 105 DIM, and the CLA cows (n = 5 each) were 
slaughtered at 42 and 105 DIM. Adipose tissues from three SC depots (tailhead, 
withers, and sternum) and from three VC depots (omental, mesenteric, and 
retroperitoneal) were sampled. Hematoxylin-eosin staining was done to measure 
adipocyte area (µm²). Retroperitoneal adipocyte sizes were mostly larger than 
adipocytes from the other sites independent of lactation time and treatment. Significant 
changes related to duration of lactation were limited to retroperitoneal fat: adipocyte 
sizes were significantly smaller at 105 DIM than at 1 DIM in CON cows. Adipocyte 
sizes were decreased in SC from tailhead at 105 DIM and from sternum at 42 DIM in 
CLA versus CON cows, whereas for VC depots adipocyte sizes were decreased in 
mesenteric fat at 42 and 105 DIM, and in omental and retroperitoneal fat, at 105 DIM in 
CLA versus CON cows. Within the CLA group, adipocyte sizes were smaller in the SC 
from the tailhead at 105 DIM than at 42 DIM. Adipocyte sizes and depot weights were 
significantly correlated in SC depots (r = 0.795, P < 0.01) in the CLA group and in 
retroperitoneal fat both in the CON (r = 0.698, P < 0.01) and the CLA (r = 0.723, P < 
0.05) group. In conclusion, CLA-induced decreases in adipocyte size indicate lipolytic 
or antilipogenic effects of CLA, or both effects, on adipose tissue in primiparous dairy 
cows. 
Key words: adipocyte, conjugated linoleic acid, dairy cow, lactation 
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Introduction 
 
The most metabolically stressful period in dairy cows is the early lactation, when milk 
production abruptly rises and an enormous metabolic drain is imposed on the body. The 
energy requirements at this period exceed the available energy from feed intake, 
resulting in a condition of negative energy balance (NEB). High-yielding dairy cows are 
then susceptible to various metabolic disorders and compromised immune response and 
fertility (Butler and Smith, 1989; Mallard et al., 1998). To meet the nutritional demands 
of milk synthesis, dairy cows need to mobilize body reserves (Bauman and Elliot, 
1983). When the decrease in body fat is refined (i.e., taking the share of different fat 
depots into consideration), the proportional change in different time intervals after 
calving is different when comparing the subcutaneous (SC) depots with different 
visceral (VC) depots (Butler-Hogg et al., 1985).  
Conjugated linoleic acid (CLA) comprises a group of geometric and positional 
conjugated dienoic isomers produced during biological or industrial hydrogenation of 
linoleic acid (C18:2, n-6). Cis-9, trans-11 (c9,t11) is the predominant natural CLA 
isomer occurring exclusively in ruminant meat and milk; commercially available CLA 
preparations contain this isomer together with the trans-10, cis-12 (t10,c12) isomer in 
equimolar concentrations (Poirier et al., 2006). Conjugated linoleic acid has attracted 
considerable attention because of their antiobesity, anticarcinogenic, antiatherogenic, 
antidiabetogenic and immunomodulating properties in certain animal models (Belury, 
2002; McLeod et al., 2004). Dietary CLA supplementation alters lipid metabolism and 
causes a reduction in milk fat secretion in lactating animals (Loor and Herbein, 1998; 
Ringseis et al., 2004). The t10,c12 isomer has been reported to be specific for the 
mammary gland and responsible for the decreased milk fat synthesis in lactating dairy 
cows (Baumgard et al., 2001), whereas the c9,t11 isomer had less effect (Perfield II et 
al., 2007). Nevertheless, the t10,c12 isomer causes a decreased body fat accretion in 
growing animals by decreasing de novo lipogenesis (Bauman et al., 2000). In addition, 
dietary CLA supplementation has been found to decrease body fat mass in several 
monogastric species such as in pigs (Ostrowska et al., 1999), mice (Poirier et al., 2005; 
Halade et al., 2010) and also in obese humans (Blankson et al., 2000). Studies with 
bovine preadipocyte culture suggest that the t10,c12 isomer inhibited differentiation of 
preadipocytes to mature adipocytes (House et al., 2005; Smith et al., 2009; Lengi and 
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Corl, 2010). Moreover, CLA-induced decrease in body fat mass in rats was due to a 
decrease in adipocyte size rather than adipocyte number (Azain et al., 2000). However, 
CLA supplementation seems to leave body fat unaffected because BCS and NEFA and 
leptin concentrations were not different from untreated controls (CON) at least when 
using relatively short treatment periods in dairy cows (Baumgard et al., 2002; Kay et al., 
2006). To our knowledge, no report about body fat-decreasing effects of CLA in dairy 
cows exists, but more detailed histological studies of adipose tissues, in particular 
addressing the heterogeneity of SC versus VC fat depots are lacking. Therefore, we 
assessed the mean adipocyte areas (µm²) of SC and VC to characterize 6 different fat 
depots in terms of adipocyte size and to investigate: 1) what physiological changes in 
adipocyte size of different fat depots occur in primiparous dairy cows during the first 
105 DIM, and 2) whether and to what extent a rumen-protected CLA supplement 
changes the adipocyte size of different fat depots in dairy cows.  
 
Materials and methods 
 
Animals, diets, and treatments 
 
The animal experimentation was done according to the European Union Guidelines and 
was approved by the Lower Saxony State Office for Consumer Protection and Food 
Safety (LAVES, File number 33.11.42502-04-071/07), Oldenburg, Germany. The 
experimental design and main results with regard to performance and body composition 
are described elsewhere (von Soosten et al., 2010). In brief, German Holstein-Friesian 
cows (n = 25) with a mean BCS of 3.0 (scale = 1 to 5) were housed in a free-stall barn 
at the Experimental Station of the Institute of Animal Nutrition, Friedrich-Loeffler-
Institute (FLI), Braunschweig, Germany. The cows were fed according to the 
recommendations of the German Society of Nutrition Physiology (GfE, 2001). Water 
was provided ad libitum. Before parturition, cows received a diet consisting of a partial 
mixed ration (PMR, 60% corn silage and 40% grass silage, 6.7 MJ of NEL/kg of DM) 
on a DM basis ad libitum and 2 kg of concentrate/d (6.7 MJ of NEL/kg of DM). The 
feed ingredients and chemical composition of the postpartum diets fed from parturition 
until slaughter with the FA profiles of the fat supplements used are shown in Table 1.  
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The cows were randomly allocated to either the CON (n = 15) or the CLA  
(n = 10) group. From 1 DIM until sample collection, the CLA cows were fed 100 g of 
rumen-protected CLA (Lutrell pure; BASF, Ludwigshafen, Germany) per d, containing 
equal proportions of each of the c9,t11 and t10,c12 isomer. The pelleted CLA-
concentrate contained about 6% each of the CLA isomers (calculated proportion in the 
CLA-concentrate; D. von Soosten, FLI, Braunschweig, Germany, personal 
communication). For the CON group, CLA were substituted by 100 g of an analogous 
fatty acid mixture (Silafat, BASF). The CON cows (n = 5 each) were slaughtered at 1, 
42, and 105 DIM, whereas the CLA cows (n = 5 each) were slaughtered at 42 and 105 
DIM. Energy balance was calculated according to the recommendations of the German 
Society of Nutrition Physiology (GfE, 2001).  
 
Measurements and sample collection 
 
At slaughter, adipose tissue samples from SC and VC depots were immediately excised 
from the cows. Adipose tissues from three SC depots (tailhead, withers and sternum) 
and from three VC depots (omental, mesenteric and retroperitoneal) were sampled. The 
mesenteric fat was collected from the fat around the jejunum and the retroperitoneal fat 
was sampled from the pararenal fat, located superficial to the renal fascia. All adipose 
tissue depots were then dissected and weighed. Milk samples were taken twice per 
week. Blood was collected in Vacutainer tubes containing sodium heparin or potassium 
EDTA (Becton Dickinson Vacutainer Systems USA, Rutherford, NJ) on the day of 
slaughter by venipuncture before slaughtering. Blood samples were analyzed for plasma 
concentrations of NEFA and BHBA with commercial kits (NEFA-C, Wako Chemicals 
GmbH, Neuss and RANBUT, Randox Laboratories GmbH, Wülfrath, Germany). The 
empty BW (EBW) was calculated as sum of the weights of all body parts of the cows 
which were recorded during the slaughter process without claws cut off, ingesta, and 
contents of urinary and gall bladder.  
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Histomorphology 
 
Adipose tissue samples (n = 150) were fixed in 4% paraformaldehyde (Roth, Karlsruhe, 
Germany) overnight, dehydrated with an ascending graded series of isopropanol (Roth), 
cleared in Rotihistol (Roth), infiltrated with a mixture of Rotihistol and melted paraffin 
(50:50 mixture) at 60ºC and finally embedded into paraffin wax. Ten-micrometer-thick 
tissue sections were cut on a rotation microtome (SLEE, Mainz, Germany) cooled with 
Cryospray (Roth) and mounted on SuperFrost Plus slides (Menzel, Braunschweig, 
Germany). They were dried at 60°C for 2 h and subsequently at 37°C for overnight. 
After deparaffinizing in Rotihistol followed by rehydration with a descending graded 
series of isopropanol, finally the sections were stained with Mayer’s hematoxylin 
(Merck, Darmstadt, Germany) and 1% wt/vol eosin Y (AppliChem, Darmstadt) and 
mounted with Kaiser’s glycerol gelatine (Merck). All stained tissue sections were 
studied by light microscopy by one person to avoid individual variation and samples 
were blind-analyzed to prevent any bias. From each stained section, five random images 
were taken at 100× magnification on a light microscope (Leica DMR, Leica 
Microsystems, Wetzlar, Germany) with a JVC digital color camera KY-F75U (Hachioji 
Plant of Victor Company, Tokyo, Japan) connected to a computer. Adipocyte areas of 
100 adipocytes from five randomly selected fields per section were measured using 
DISKUS software (4th version; Hilgers, Koenigswinter, Germany) and then averaged. 
The unit of mean adipocyte area was square micrometer (µm²).  
 
Statistical analyses  
 
Data for all variables (EBW, depot weight, adipocyte area, energy balance, and plasma 
NEFA and BHBA concentrations) were tested for normal distribution with the 
Kolmogorov-Smirnov test and for homogeneity of variances with the Levene's test. 
Statistical analyses were made using general linear model (GLM) followed by a 
Bonferroni post-hoc test to compare the differences within the CON groups and within 
the fat depots of both CON and CLA groups. For GLM, significance was defined as P < 
0.05 and trends for physiological responses were declared at P < 0.10. The Student’s t-
test was used to analyze the differences between the CON and the CLA group at 42 and 
105 DIM as well as within the CLA group on the respective day. Therefore, the 
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threshold for statistical significance was defined as P < 0.017 after the Bonferroni α-
correction for multiple comparisons (n = 3; α = 0.05/3 = 0.017). Pearson correlation 
coefficients were used to examine the relations between adipocyte sizes and depot 
weights of different adipose tissues, and between adipocyte sizes and plasma NEFA and 
BHBA concentrations, respectively. All analyses were done using SPSS software, 
version 17.0 (SPSS, Inc., Chicago, Illinois). Values are given as means ± SEM.  
 
Results 
  
The animals were in NEB at 1 DIM, whereas higher (P < 0.001) and positive EB values 
were reached in both groups by 42 and 105 DIM (Fig. 1). Empty BW was not different 
between sampling day or groups; EBW was numerically lower at 42 DIM  
(P < 0.10) than at 1 DIM in CON cows and lower than at 105 DIM in both CON and 
CLA cows (Table 2). Comparing the different fat depot weights from 1, 42, and 105 
DIM, differences (P < 0.05) were limited to the retroperitoneal depot for which 52 and 
63% of the mass recorded at 1 DIM were reached at 42 and 105 DIM, respectively 
(Table 2). For all other depots, numerical decreases, not reaching the level of 
significance, were observed from 1 to 42 DIM. From 42 to 105 DIM, numerical, but 
insignificant, increases were noticed for SC and omental fat, but not for mesenteric fat 
in the CON cows. In CLA cows, all fat depots were consistently lighter at 105 versus 42 
DIM, but again, the differences did not reach the level of significance (Table 2).  
 
Plasma NEFA and BHBA concentrations  
 
In CON cows, plasma NEFA concentrations were higher at 1 DIM than at 42 DIM (2.4-
fold; P = 0.01) and at 105 DIM (2.6-fold; P = 0.007), respectively. No differences 
existed in CLA versus CON groups and also within the CLA group (Fig. 1). Concerning 
plasma BHBA concentrations, no differences were observed within the CON group, 
between the CON and the CLA group, or within the CLA group. 
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Histomorphological study 
 
Histomorphological examination revealed that the adipocytes were individually held in 
place by delicate reticular fibers clustering in lobules bounded by fibrous septa within 
the adipose tissue both in SC and VC depots. In SC depots, higher portions of 
connective tissue fibers were found than in VC depots (Fig. 2). Typical, unilocular, 
signet-ring shaped adipocytes and small multilocular adipocytes were found in all the 
fat depots examined. Small arteries and venules were present within the septa in all 
adipose tissues.  
 
Adipocyte sizes of different fat depots in CON and CLA cows 
 
In CON cows, retroperitoneal adipocyte sizes were 1.4-fold larger (P = 0.01) than in SC 
depot from the sternum at 1 DIM (Table 3). Adipocyte sizes tended to be larger (P < 
0.10) in retroperitoneal fat than that of SC depots from the tailhead and withers and of 
VC depot from mesenteric fat in CON cows at 1 DIM. The same trend (P < 0.10) for 
larger adipocyte size was also found in retroperitoneal fat when compared with SC 
depot from the withers in CON cows at 105 DIM. In CLA cows, retroperitoneal 
adipocyte sizes were 1.4-fold larger than those in SC depots from the withers (P = 
0.041) and sternum (P = 0.037) at 42 DIM (Table 3). Representative pictures of an SC 
depot (from tailhead) and also of a VC depot (from retroperitoneal) are shown in Fig. 2 
for each treatment and sampling day. 
 
Influence of lactation time on adipocyte size during early lactation 
  
No effect of duration of lactation on adipocyte sizes of SC depots from the tailhead and 
sternum in CON cows was observed. Adipocyte sizes of SC depot from the withers in 
CON cows tended to be smaller (P < 0.10) at 105 DIM than at 1 DIM (Table 3). 
Conversely, for VC depots, significant changes related to the duration of lactation were 
limited to retroperitoneal fat. In CON cows, retroperitoneal adipocyte sizes were 1.2-
fold smaller (P < 0.05) at 105 DIM than at 1 DIM (Table 3), and tended to be smaller (P 
< 0.10) at 42 DIM than at 1 DIM. Moreover, no effect of duration of lactation on 
adipocyte sizes of omental and mesenteric fat depots was observed.  
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Effects of CLA on adipocyte size during early lactation  
 
The SC depot from the tailhead had 1.9-fold smaller (P = 0.001) adipocyte sizes in CLA 
cows than in CON cows at 105 DIM, whereas SC depot from the sternum had 1.3-fold 
smaller (P = 0.01) adipocyte sizes in CLA cows than in CON cows at 42 DIM (Table 
3). For VC depots, the adipocyte size was decreased 1.5-fold (P = 0.011) in omental fat 
in CLA versus CON cows at 105 DIM. In mesenteric fat, adipocyte size was 1.5-fold 
smaller in CLA cows than in CON cows both at 42 DIM (P = 0.002) and 105 DIM (P = 
0.008) each. Moreover, the adipocyte size of retroperitoneal fat was 1.5-fold smaller (P 
= 0.006) in CLA versus CON cows at 105 DIM (Table 3). Within the CLA group, 
adipocyte size of SC depot from the tailhead was decreased 1.4-fold (P = 0.005) from 
42 to 105 DIM (Table 3). To assess the extent of CLA effects, percentage differences 
(%) between adipocyte sizes of different fat depots of CON and CLA groups were 
calculated; for both sampling days, the corresponding CON group was taken as 100%. 
Conjugated linoleic acid supplemented cows had 16, 22, and 24% numerical decreases 
in adipocyte sizes in SC depots from the tailhead, withers, and sternum, respectively, 
compared with the CON cows at 42 DIM, whereas 47, 33, and 29% numerical decreases 
in adipocyte sizes were observed in SC depots from the tailhead, withers and sternum, 
respectively, in CLA cows compared with the CON cows at 105 DIM. For VC depots, 
the CLA cows had 22, 32, and 16% numerical decreases in adipocyte sizes in omental, 
mesenteric, and retroperitoneal fat, respectively, compared with the CON cows at 42 
DIM, whereas 32, 33, and 34% numerical decreases in adipocyte sizes were observed in 
omental, mesenteric, and retroperitoneal fat, respectively, in CLA cows compared with 
the CON cows at 105 DIM.  
 
Correlations between adipocytes sizes and depot weights of different adipose tissues  
 
We examined the correlation between adipocyte areas and depot weights of SC and 
different VC depots at 1, 42, and 105 DIM. For the entire SC depot, the correlation was 
calculated between the mean adipocyte areas of all 3 SC depots examined and the 
weight of the entire SC fat. In CON cows, a strong positive correlation was found in 
retroperitoneal fat depot (r = 0.698, P = 0.004, n = 15). In CLA cows, strong positive 
relationships were observed in the SC depot (r = 0.795, P = 0.006, n = 10) and in the 
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retroperitoneal depot (r = 0.723, P = 0.018, n = 10). Very strong relationships were 
found in retroperitoneal depot both in CON (r = 0.905, P = 0.035, n = 5) and CLA cows  
(r = 0.892, P = 0.042, n = 5) at 105 DIM. 
 
Correlations between adipocytes sizes and plasma NEFA and BHBA concentrations 
 
We examined the correlation between adipocyte areas of different SC and VC depots 
and plasma NEFA and BHBA concentrations, respectively, at 1, 42, and 105 DIM. In 
CON cows, a strong positive correlation was found between retroperitoneal adipocyte 
sizes and plasma NEFA concentrations (r = 0.698, P = 0.004, n = 15), whereas no 
significant relationships were detectable in any of the fat depots from the CLA cows 
(Table 4). A very strong inverse relationship was found between SC adipocyte sizes 
from withers and plasma NEFA in CON cows at 42 DIM (r = –0.990, P = 0.001, n = 5). 
However, no significant relationships were found between adipocyte sizes and plasma 
BHBA concentrations in any of fat depots from the CON cows, whereas a strong 
positive correlation was found only in the SC depot from the sternum (r = 0.651, P = 
0.041, n = 10) in CLA cows. Very strong positive relationships were found in omental 
depot of CON cows (r = 0.879, P = 0.05, n = 5) and in SC depots from the tailhead (r = 
0.989, P = 0.001, n = 5) and from the sternum (r = 0.880, P = 0.049, n = 5) of CLA 
cows at 105 DIM (Table 4). 
 
Discussion 
 
The experimental primiparous cows experienced NEB on first sampling day at 1 DIM, 
but were returned to positive EB on the day of second slaughter series i.e., 42 DIM 
irrespective of CLA treatment. This is in contrast to the duration of NEB in pluriparous 
cows (Bauman and Currie, 1980). However, the trend for lower EBW at 42 DIM than at 
1 DIM might reflect the effects of the preceding NEB; conversely, numerically higher 
EBW at 105 DIM than at 42 DIM may indicate the effects of positive EB in dairy cows, 
irrespective of CLA treatment (Table 2; Fig. 1).  
The size of adipocytes within an individual can vary considerably from depot to depot. 
It has been reported that the adipocytes from retroperitoneal fat have consistently larger 
adipocyte areas than the adipocytes from SC, omental and mesenteric fat depots in cows 
Manuscript 1   27 
(Pike and Roberts, 1984). In the present study, we found that the adipocytes from 
retroperitoneal fat had significantly larger adipocyte areas than that of SC from the 
sternum in CON cows at 1 DIM. A tendency of increasing adipocyte size of 
retroperitoneal fat compared to that of SC depots from the tailhead and withers and of 
VC depot from mesenteric fat in CON cows at 1 DIM was observed. This could be 
related to metabolic differences between adipocytes from various depots, as known 
from monogastric species (Arner, 1998). Indeed, gene expression profiles from SC and 
VC fat depots in cattle (Hishikawa et al., 2005) support the notion of characteristic 
biochemical differences in these depots. 
 
Physiological changes of adipocyte size during early lactation  
 
Bovine adipose tissue undergoes coordinated metabolic adaptations via a decrease in de 
novo lipogenesis and an increase in rates of lipolysis during early lactation (McNamara 
and Hillers, 1986). In the present study, we observed the physiological changes of 
adipocyte sizes of different fat depots during the first 105 DIM. Adipocytes from 
different regions have been reported to show a differential response during pregnancy 
and lactation in women, due to the condition of changing fat cell metabolism in 
different regions (Rebuffe-Scrive et al., 1985). Fat mobilization occurs in cows from 
late pregnancy through to midlactation, and the different depots respond to changing 
physiological states in different ways. Butler-Hogg et al. (1985) estimated from their 
dissection experiments that the rates of change on a g/d basis are highest from calving to 
peak-lactation (42 DIM) in all depots whereby the intermuscular and the SC depots are 
the main contributors. Until midlactation (154 DIM), the rate of change in SC fat was 
only about 1% of the rate of change observed during the preceding period, whereas 
omental and mesenteric fat were further mobilized at 13 and 28% of the preceding rate. 
Perirenal retroperitoneal fat was not further decreased after peak-lactation (Butler-Hogg 
et al., 1985). In our study, we found that the adipocyte size of retroperitoneal fat was 
1.2-fold smaller in CON cows at 105 DIM than at 1 DIM, and also tended to be smaller 
at 42 DIM than at 1 DIM, suggesting that retroperitoneal fat was preferentially 
mobilized during peak-lactation. This finding is in agreement with the aforementioned 
study (Butler-Hogg et al., 1985). Moreover, the retroperitoneal fat depot weight was 
significantly decreased at 42 DIM and numerically decreased at 105 DIM compared 
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with 1 DIM, suggesting that the retroperitoneal fat depot reacted most sensitively to the 
advancement of lactation.  
Although significant changes related to duration of lactation were limited to 
retroperitoneal fat, data in Table 3 showed numerically decreased adipocyte size up to 
105 DIM in almost all of the fat depots examined. Active ongoing lipolysis, as evident 
from plasma NEFA concentrations, was thus, limited to the first sampling day at 1 DIM 
(Fig. 1). This rapid rise in plasma NEFA might be due to the stress of calving 
(Grummer, 1995). However, the time course of adipocyte decrease accompanying or 
following lipolysis or both, has not been characterized, at least to our knowledge. We 
thus speculate that the effects of lipolysis on adipocyte size were continued up to 105 
DIM.  
 
CLA-induced changes of adipocyte size during early lactation  
 
The efficacy of the CLA supplementation in terms of milk fat decrease was confirmed 
in dairy cows during early lactation (D. von Soosten and S. Dänicke, FLI, 
Braunschweig, Germany, unpublished observations). We herein demonstrate for the 
first time CLA-induced changes of adipocyte size in dairy cows during early lactation. 
It has been reported that CLA decreased adipocyte size in rats, as to the significant 
reduction in mean adipocyte diameter (Sisk et al., 2001). The use of mean adipocyte 
diameter is an alternative method for estimating body fat and adipose tissue cellularity 
in lactating cows (Waltner et al., 1994).  
The body fat-decreasing effects of CLA have been also reported in other studies in rats 
(Azain et al., 2000; Noto et al., 2007) and pigs (Corino et al., 2005). Those studies were 
limited in that the adipocyte size was measured in only one fat depot (i.e., SC). DeLany 
et al. (1999) showed that dietary CLA supplementation decreased body fat 
accumulation in VC depots in mice. Poulos et al. (2001) found that CLA increased the 
proportion of smaller adipocytes and decreased the proportion of larger adipocytes of 
retroperitoneal fat depot in rat pups. In the present study, we observed that dietary CLA 
supplementation decreased adipocyte sizes of different SC and VC depots to different 
extents in dairy cows during the first 105 DIM. Moreover, the extent of CLA-induced 
decreased in adipocyte sizes is consistently higher at 105 DIM than at 42 DIM both for 
SC and VC depots, as indicated by the percent decreases. Specific regional metabolic 
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differences that explain the differential regional response to CLA treatment are not well 
clarified. The regional differences could be explained by differences in accretion rates 
of different fat depots during the trial (Djian et al., 1983). It has also been reported that 
adipocytes in SC and VC depots show differences in basal metabolic properties, for 
example, in regulating volume and lipid composition as well as present differential gene 
expression profiles in humans (Montague et al., 1998) and cattle (Hishikawa et al., 
2005). Within the CLA group, the adipocyte size significantly decreased only in SC 
depot from the tailhead, suggesting that the adipocyte size may not differ with the time 
of CLA supplementation.  
 
Mechanisms of action of CLA  
 
The mechanisms behind a possible fat-decreasing effect of CLA are currently not well 
clarified. Both in vitro and in vivo studies in monogastric species demonstrated that 
CLA decreases adipocyte cellularity by decreasing adipocyte proliferation (Brodie et 
al., 1999; Evans et al., 2000) or adipocyte size (Azain et al., 2000; Brown et al., 2001; 
Evans et al., 2000). The t10,c12 isomer has been associated with decreased body fat 
mass in mice, whereas no such changes in body composition have been observed using 
the c9,t11 isomer (Park et al., 1999b). The t10,c12 isomer also induces adipocyte 
apoptosis in mice (Tsuboyama-Kasaoka et al., 2000). In addition, this CLA isomer 
decreases preadipocyte differentiation by down-regulation of peroxisome proliferator-
activated receptor gamma expression in humans (Brown and McIntosh, 2003). The 
CLA preparation used in the present study contained equal amounts of c9,t11 and 
t10,c12 isomers. The effects of CLA presented in this study could, therefore, result from 
either or both of these isomers.  
The metabolic effects reported for CLA in adipose tissue suggest increased fat 
mobilization, as evidenced by increasing lipolysis and glycerol release, and decreased 
lipid deposition, as evidenced by decreasing activity of lipoprotein lipase (Park et al., 
1997). These changes in lipid metabolism were exclusively associated with the t10,c12 
isomer of CLA (Park et al., 1999b). The antilipogenic effect of CLA is accounted for by 
decreased lipid filling of adipocytes in CLA supplemented rats (Azain et al., 2000). 
Decreased rates of lipogenesis have also been suggested to be the mechanism for the 
decrease in body fat accretion in CLA supplemented humans (Brown et al., 2003), 
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growing pigs (Ostrowska et al., 1999) and mice (Tsuboyama-Kasaoka et al., 2000). 
Thus, the effects of CLA on adipogenesis and lipid metabolism in animals are isomer-, 
dose-, time-, and species-dependent (Evans et al., 2002). West et al. (1998) reported 
decreases in specific adipose tissue depots in male mice fed CLA ranging from 40 to 
80%. Spalding et al. (2008) suggested that adipocyte number remains stable in 
adulthood in lean and obese individuals, although significant weight loss can result in a 
decrease in adipocyte volume; however, the decrease in body fat mass in response to 
CLA can be attributed to decreased adipocyte size rather than adipocyte number (Azain 
et al., 2000). This basis for the reduction in fat mass is consistent with metabolic 
changes (decreased lipid deposition and increased lipolysis) and has been reported 
previously (Park et al., 1997; Park et al., 1999a, b).  
In contrast to the studies in monogastric species, whether, and to what extent, 
supplemental CLA dose changes the body fat in dairy cows is not yet been clarified. 
One mRNA expression study indicates that lipid synthesis is stimulated by short term 
CLA supplementation in adipose tissue of cows (Harvatine et al., 2009). Decreased 
rates of glucose utilization for lipid synthesis could be a mechanism by which CLA 
decrease body fat (Baumgard et al., 2002). However, in studies with shorter durations of 
CLA supplementation (up to 5 wk) than in our experiment, metabolic parameters and 
hormones such as NEFA, glucose, insulin and leptin as well as BCS were not indicating 
any systemic changes in lipid metabolism and energy homeostasis (Baumgard et al., 
2002; de Veth et al., 2006; Kay et al., 2006). In our present study, both plasma NEFA 
and BHBA concentrations were not different between CON and CLA groups. 
Moreover, a very strong inverse relationship was detectable in SC depot from the 
withers in CON cows at 42 DIM, possibly indicating lipolysis during the physiological 
changes related to early lactation. Furthermore, both in vitro and in vivo bovine studies 
suggest that BHBA may play an important role in dairy cows for its feedback inhibitory 
effect on lipolysis (Metz et al., 1974). The receptor for BHBA [i.e., G-protein-coupled 
receptor109 (GPR109)] is predominantly expressed in adipose tissues of monogastrics 
(Soga et al., 2003) and dairy cows (Lemor et al., 2009). Taggart et al. (2005) also 
reported that BHBA inhibits adipocyte lipolysis in mice via PUMA-G (also known as 
GPR109). Based on the positive correlation between adipocyte size and plasma BHBA 
from our present study, the processes of lipolysis might be increased in adipose tissues 
in a depot-specific manner both in CON and CLA supplemented cows. We, thus, 
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speculate that lipolysis might be elevated during the physiological changes related to 
early lactation. In addition, the decreases in adipocyte size that we observed in CLA 
supplemented cows may indicate lipolytic or antilipogenic effects of CLA, or both 
effects, on adipose tissue in primiparous dairy cows. 
 
Conclusions 
 
Significant physiological changes related to the duration of lactation were limited to 
retroperitoneal fat depot in CON cows during early lactation. Conjugated linoleic acid-
induced decreases in adipocyte size in the present long-term study indicate that CLA 
does affect body fat in dairy cows similar to what is known from CLA supplemented 
monogastrics. The present study suggested, for the first time, that dietary 
supplementation of CLA has site-specific effects on adipocyte size of different fat 
depots in dairy cows. These results may contribute to an improved and comprehensive 
assessment of CLA effects on animal health in dairy cows.  
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Table 1: Feed ingredients and chemical composition of the postpartum 
concentrates and partial mixed ration (PMR) 
 
 Concentrate2  
Item1 CON CLA PMR3 
Feed ingredients (%)    
Wheat grain 39.5 39.5 
 
Dried sugar beet pulp 29 29 
 
Rapeseed meal 20 20 
 
Soybean meal 6.5 6.5 
 
Vitamin/mineral premix4 2 2 
 
CON fat supplement 2.5 - 
 
CLA supplement - 2.5 
 
Calcium carbonate 0.5 0.5 
 
Analyzed chemical profile   
 
DM (g/kg) 873 871 445 
Nutrient (g/kg DM)   
 
Crude ash 65 69 62 
CP       182 180 124 
Ether extract 50 44 28 
Crude fiber 96 97 183 
ADF 134 133 208 
NDF 259 260 405 
Energy5
 
(MJ/kg DM)   
 
ME 13.9 13.7 11.9 
    NEL 8.9 8.7 7.5 
CLA4 (g/kg DM)    
   C18:2 c9,t11 0.0 1.6 0.0 
   C18:2 t10,c12 0.0 1.7 0.0 
Fatty acid profiles of fat supplements 
 
 
CON6 
 
CLA7 
 
Fatty acid  (% by wt of total fatty acids)    
Palmitic acid (C16:0) 10.89 10.89  
Stearic acid (C18:0) 87.30 50.31  
Oleic acid (C18:1 c9) <0.01 10.66  
CLA    
   C18:2 c9,t11 0.06 11.99  
   C18:2 t10,c12 0.02 11.88  
   Other CLA 0.15 0.95  
Others 1.58 3.32  
1
c = cis; t = trans. 
2CON = control; CLA = conjugated linoleic acid. 
3Partial mixed ration containing 25% grass silage, 38% corn silage and 37% PMR-concentrate  
(13.5 MJ of ME /kg of DM) on DM basis. 
4Per kilogram of mineral feed, contains: 140 g of Ca; 120 g of Na; 70 g of P; 40 g of Mg; 6 g of 
Zn; 5.4 g of Mn; 1 g of Cu; 100 mg of I; 40 mg of Se; 5 mg of Co; 1,000,000 IU of vitamin A; 
100,000 IU of vitamin D3; and 1,500 mg of vitamin E.  
5Calculation based on nutrient digestibility’s measured in rumen-cannulated wethers (GfE, 
1991). 
6CON fat supplement. 
7CLA supplement. 
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Table 2: Empty BW (EBW; kg) and different fat depot weights (kg) in control 
(CON) and conjugated linoleic acid (CLA) supplemented dairy cows 
during the first 105 DIM 
abWithin a row, means with different superscript letters differ at P < 0.05.  
1General linear model followed by Bonferroni post-hoc tests; significant P-value (P < 0.05) is highlighted in 
boldface type. 
2Student’s t-test.  
 DIM  
Item 1 42 105 P-value1 
CON (n = 15), means ± SEM     
EBW  444 ± 10.5 395 ± 12.4 432 ± 11.9 0.052 
Depot weight     
Mean Subcutaneous (SC) depot 4.32 ± 0.36 3.29 ± 0.40 3.75 ± 0.71 0.481 
Visceral (VC) depots     
Omental 11.0 ± 1.04 7.58 ± 0.53 8.53 ± 1.21 0.110 
Mesenteric 5.93 ± 0.31 4.97 ± 0.39 4.44 ± 0.46 0.094 
Retroperitoneal 8.76 ± 0.87a 4.58 ± 0.65b 5.56 ± 1.01ab 0.024 
CLA (n = 10), means ± SEM    P-value2 
EBW   399.3 ± 10.94 410.66 ± 18.60 0.650 
Depot weight     
Mean SC depot  4.86 ± 0.83 2.98 ± 0.51 0.123 
VC depots     
Omental  9.11 ± 1.12 7.40 ± 1.06 0.347 
Mesenteric  5.87 ± 0.68 4.48 ± 0.50 0.184 
Retroperitoneal  5.78 ± 0.91 4.27 ± 0.87 0.311 
CON vs. CLA    P-value2  
EBW  0.836 0.418  
Depot weight     
Mean SC depot  0.169 0.449  
VC depots     
Omental  0.297 0.546  
Mesenteric  0.360 0.980  
Retroperitoneal  0.363 0.403  
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Table 3: Adipocyte sizes (µm²) of different fat depots in control (CON) and 
conjugated linoleic acid (CLA) supplemented dairy cows during the first 
105 DIM 
 
a,bWithin a column, means with different superscript letters differ at P < 0.05.  
yzWithin a row, means with different superscript letters differ at P < 0.05 for GLM and P < 0.017 for Student’s t-
test.  
1GLM, followed by Bonferroni post-hoc tests; significant P-value (P < 0.05) is highlighted in boldface type. 
2Student’s t-test, after the Bonferroni α-correction for multiple comparisons; significant differences (P < 0.017) 
are highlighted in boldface type.  
 
 DIM  
Item 1  42  105  P-value1 
CON (n = 15; means ± SEM)     
Subcutaneous (SC) depots     
Tailhead 6,300 ± 448ab 5,442 ± 408 6,103 ± 325 0.389 
Withers 6,258 ± 451ab 5,110 ± 407 4,521 ± 390 0.060 
Sternum 5,782 ± 243b 5,180 ± 314 4,831 ± 454 0.257 
Visceral (VC) depots     
Omental 6,381 ± 372ab 6,077 ± 289 5,851 ± 286 0.587 
Mesenteric 6,172 ± 294ab 6,222 ± 267 5,784 ± 436 0.682 
Retroperitoneal 7,945 ± 208a,y 6,634 ± 234yz 6,500 ± 414z 0.019 
CLA (n = 10; means ± SEM)    P-value2 
SC depots     
Tailhead  4,573 ± 291ab,y 3,233 ± 127z 0.005 
Withers  3,976 ± 332b 3,021 ± 583 0.239 
Sternum  3,959 ± 87b 3,452 ± 329 0.220 
VC depots     
Omental  4,750 ± 277ab 3,997 ± 410 0.211 
Mesenteric  4,235 ± 296ab 3,902 ± 207 0.433 
Retroperitoneal  5,552 ± 407a 4,316 ± 335 0.070 
CON vs. CLA    P-value2  
SC depots     
Tailhead  0.160 0.001  
Withers  0.090 0.092  
Sternum  0.010 0.059  
VC depots     
Omental  0.018 0.011  
Mesenteric  0.002 0.008  
Retroperitoneal  0.074 0.006  
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Table 4: Coefficients of significant correlations between adipocyte sizes of 
different fat depots and plasma concentrations of NEFA and BHBA 
in control (CON) and conjugated linoleic acid (CLA) supplemented 
dairy cows during the first 105 DIM 
1Mean CON comprising the control fat supplemented cows from 1, 42, and 105 DIM (n = 15). 
2Mean CLA comprising the CLA supplemented cows from 42 and 105 DIM (n = 10). 
* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 NEFA  BHBA 
CON  Mean  CON1 
1 DIM 42 DIM 105 DIM  
 
Mean  
CON1 
1 DIM 42 DIM 105 DIM 
  n = 5 each   n = 5 each 
Subcutaneous (SC) depots          
tailhead - - - -  - - - - 
withers     - - – 0.990*** -  - - - - 
sternum - - - -  - - - - 
Mean SC depot - - - -  - - - - 
Visceral (VC) depots          
Omental - - - -  - - -  0.879* 
Mesenteric - - - -  - - - - 
Retroperitoneal  0.698** - - -  - - - - 
Mean VC depot   0.602* - - -  - - - - 
CLA  Mean  CLA2 
    
 
Mean  
CLA2 
   
SC depots          
tailhead -  - -  -  -  0.989** 
withers -  - -  -  - - 
sternum -  - -   0.651*     - 0.880* 
Mean SC depot -  - -   0.657*  - 0.901* 
VC depots          
Omental -  - -  -  - - 
Mesenteric -  - -  -  - - 
Retroperitoneal -  - -  -  - - 
Mean VC depot -  - -  -  - - 
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Fig. 1: Energy balance and plasma concentrations of NEFA and BHBA of 
control (CON) and conjugated linoleic acid (CLA) supplemented 
dairy cows during the first 105 DIM. Each group represents the mean 
± standard error of the means of 5 animals. ** P < 0.01; *** P < 0.001. 
Net energy balance (MJ NEL/d) = energy intake (MJ NEL/d) – [NEM (MJ 
NEL/d) + NEL (MJ NEL/d)]. 
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Fig. 2: Histological sections of the subcutaneous (SC) fat depot from the 
tailhead (left column) and of the retroperitoneal visceral (VC) fat 
depot (right column) from control (CON) and conjugated linoleic 
acid (CLA) supplemented dairy cows at 1, 42, and 105 DIM. Higher 
portions of connective tissue fibers were found in SC depots than in VC 
depots. Hematoxylin-eosin staining. Original magnification 100×; Scale 
bar = 200 µm; CT = connective tissue fibers.  
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Abstract 
 
This present study aimed to investigate whether phagocytic immune cells infiltrate into 
bovine adipose tissue (AT) and to study the effects of lactation and conjugated linoleic 
acid (CLA) supplementation on the invasion of phagocytic immune cells into different 
subcutaneous (SC) and visceral (VC) fat depots of primiparous dairy cows during the 
first 105 days in milk (DIM). German Holstein-Friesian cows (HF; n = 25) with a mean 
body condition score (BCS) of 3.0 were divided into a control (CON) and a CLA group. 
From 1 DIM until sample collection, CLA cows were fed 100 g of CLA supplement/d 
(about 6% of c9,t11 and t10,c12 isomers each), whereas the CON cows received 100 
g/d of a fatty acid mixture instead of CLA. The CON cows (n = 5 each) were 
slaughtered at 1, 42, and 105 DIM, and the CLA cows (n = 5 each) were slaughtered at 
42 and 105 DIM. Adipose tissues (AT; n = 150) from three SC (tailhead, withers, and 
sternum) and three VC (omental, mesenteric, and retroperitoneal) depots were sampled. 
In addition, SC tailhead biopsies were collected by repeated surgical biopsies (three 
samplings within 7 wk; n = 36) from 12 non-pregnant, non-lactating Simmental heifers 
(SM; mean BCS = 5.0) fed diets of varying energy density to compare the changes in 
phagocytic immune cell infiltration with early-lactating cows. Immunohistochemical 
analyses of different fat depots revealed a low incidence of phagocytic immune cell 
infiltration in early-lactating cows. The portion of infiltrating macrophages (CD68+) in 
a few positive AT samples of HF cows was slightly lower in SC versus VC fat and was 
positively correlated with both empty body weight and adipocyte size. However, no 
differences with regard to DIM and CLA supplementation were observed in HF cows. 
Increased accumulation of phagocytic immune cells, albeit at low cell numbers in non-
pregnant, over-conditioned SM heifers might be related to larger adipocytes secreting 
higher amounts of chemoattractant adipokines compared with the early-lactating cows. 
In conclusion, the extent of fatness in HF cows may not be high enough to stimulate 
significant infiltration of phagocytic cells in AT and therefore, these immune cells 
might have no major role in the immunologic and metabolic adaptations during early 
lactation.  
 
Key words: adipose tissue, dairy cow, early lactation, immune cell infiltration 
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Introduction 
 
During early lactation, dairy cows undergo coordinated metabolic adaptations, mainly 
due to the excessive energy demands imposed by the lactating udder (Bauman and 
Currie, 1980). High-yielding cows then undergo comprehensive metabolic adaptations 
with fat mobilization, decreased insulin sensitivity, and immunosuppression being 
major issues (Butler and Smith, 1989; Mallard et al., 1998). The energy requirements at 
this period can not entirely be met through dietary intake, and energy has to be 
mobilized from body reserves, mainly from adipose tissue (AT), thus resulting in a state 
of negative energy balance (NEB). Besides its function as an energy storage depot, AT 
secretes endocrine factors that exert a dichotomic function both in metabolism and 
immunoregulation; AT thus forms a gateway connecting metabolism with innate 
immunity (Schäffler and Schölmerich, 2010). The major phagocytic cells of the innate 
immune system include neutrophils, monocytes, and macrophages, which originate 
from the myeloid progenitors in the bone marrow (Noorman et al., 1997; Weisberg et 
al., 2003). Neutrophils circulate in the blood and are readily attracted to sites of 
inflammation (Schymeinsky et al., 2007). Monocytes are also circulating cells, which 
eventually evade into tissues and differentiate into macrophages (Hume et al., 2002). 
These immune cells have the ability to phagocytize directly; among them, macrophages 
are highly effective phagocytes acting in innate immunity and tissue remodeling via 
cytokine secretion and apoptotic body clearance (Duffield, 2003; Saillan-Barreau et al., 
2003). Tissue macrophages can be identified via flow cytometry or 
immunohistochemical staining by their specific expression of a number of proteins 
including CD68, CD14, CD11b, and CD11c (Khazen et al., 2005). CD68 is the main 
macrophage-specific marker; however, Noorman et al. (1997) reported that commonly 
used macrophage markers are also expressed on monocytes (CD14; CD11b; CD11c) or 
on granulocytes (CD11b). In the context of obesity and high-fat diet, humans and mice 
exhibit increased infiltration of AT macrophages (ATM), particularly in visceral (VC) 
depots to form a proinflammatory micro-milieu causing local and systemic insulin 
resistance (Weisberg et al., 2003; Xu et al., 2003; Nishimura et al., 2009). This 
phenomenon is associated with changing adipokine profiles and positively correlates 
with adipocyte size and body fat mass (Weisberg et al., 2003). Moreover, AT 
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neutrophils transiently infiltrate prior to the infiltration of ATM in diet-induced obese 
mice (Elgazar-Carmon et al., 2008). 
Conjugated linoleic acid (CLA) designates a group of naturally occurring dienoic 
derivatives of linoleic acid. Cis-9, trans-11 (c9,t11) is the predominant natural CLA 
isomer occurring exclusively in ruminant meat and milk, whereas commercially 
available CLA preparations contain this isomer together with the trans-10, cis-12 
(t10,c12) in equimolar concentrations (Poirier et al., 2006). Isomers of CLA have a wide 
range of beneficial effects, such as anticarcinogenic, antiatherogenic, antidiabetic, and 
antiobesity (Bauman et al., 2001). In vitro and in vivo studies also demonstrate that 
CLA modulates immune function (O'Shea et al., 2004). Supplementation of dairy cows 
with CLA has recently been reported to decrease milk fat but left body fat mostly 
unaffected in terms of depot mass (von Soosten et al., 2011). However, when 
considering adipocyte sizes, CLA supplemented cows had smaller adipocytes both in 
subcutaneous (SC) and VC fat depots compared with control (CON) cows (Akter et al., 
2011). Nevertheless, the t10,c12 isomer promotes ATM infiltration (Poirier et al., 
2006), whereas the c9,t11 isomer decreases this phenomenon in mice (Moloney et al., 
2007). 
So far, most research on ATM infiltration has focused on their contribution to the 
development of obesity-associated pathologies through systemic effects in nonruminant 
species (Bouloumié et al., 2005; Schäffler and Schölmerich, 2010). To our knowledge, 
no report exists about phagocytic immune cell infiltration into bovine AT. Therefore, 
we aimed to investigate: 1) whether phagocytic immune cells infiltrate into SC and VC 
fat depots of primiparous dairy cows during the first 105 DIM and 2) whether or not 
dietary CLA supplements would have any effect on this infiltration phenomenon. 
Immunohistochemistry was performed on AT cryosections to characterize the portion of 
CD68+, CD14+, CD11b+, and CD11c+ cells in AT of early-lactating dairy cows. In 
addition, the changes in the portion of phagocytic immune cells in AT of early-lactating 
cows were compared with non-pregnant, over-conditioned heifers and fat steers. 
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Materials and methods 
 
Animals, experimental designs, and diets 
 
Trial 1: Early-lactating cows. The animal experiment was conducted according to the 
European Union guidelines and was approved by the Lower Saxony State Office for 
Consumer Protection and Food Safety (LAVES), Oldenburg, Germany (File number 
33.11.42502-04-071/07). The details of this study have been described previously (von 
Soosten et al., 2011). In brief, German Holstein-Friesian cows (HF; n = 25) with a mean 
BCS of 3.0 (scale = 1 to 5) were housed in a free-stall barn at the experimental station 
of the Institute of Animal Nutrition, Friedrich-Loeffler-Institute (FLI), Braunschweig, 
Germany. The animals were fed according to the recommendations of the German 
Society of Nutrition Physiology (GfE, 2001). Water was provided ad libitum. Before 
parturition, cows received a diet consisting of a partial mixed ration (PMR, 60% corn 
silage and 40% grass silage on a DM basis; 6.7 MJ NEL/kg DM) for ad libitum intake 
and 2 kg concentrate/d (6.7 MJ NEL/kg DM). After parturition, they were fed a PMR 
(25% grass silage, 38% corn silage and 37% PMR-concentrate on a DM basis) for ad 
libitum intake (7.5 MJ NEL/kg DM). Additionally, 4 kg of concentrate (DM basis; 8.9 
MJ NEL/kg DM for CON cows and 8.7 MJ NEL/kg DM for CLA cows), which 
contained the control fat supplement or the CLA supplement, was provided by the 
computerized concentrate feeding stations (type RIC; Insentec, B.V., Marknesse, the 
Netherlands) in pelleted form and water was available ad libitum from parturition until 
slaughter.  
The cows were randomly allocated to either the CON (n = 15) or the CLA  
(n = 10) group. From 1 DIM until sample collection, the CLA cows were fed 100 g/d of 
a rumen-protected (lipid encapsulation technique) CLA supplement (Lutrell Pure, BASF 
SE,  Ludwigshafen, Germany) and the CON cows received 100 g/d of a fatty acid 
mixture (Silafat, BASF SE). The pelleted CLA-concentrate contained about 6% each of 
the t10,c12 and c9,t11 isomers (calculated proportion in the CLA-concentrate). The 
CON animals (n = 5 each) were slaughtered at 1, 42, and 105 DIM, whereas the CLA 
cows (n = 5 each) were slaughtered at 42 and 105 DIM.  
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Trial 2: Non-pregnant, over-conditioned heifers. The animal experiment was approved 
by the North Rhine-Westphalia State Agency for Nature, Environment, and Consumer 
Protection (LANUV-NRW), Recklinghausen, Germany (File number 
8.87.51.05.20.10.103). Adult, non-pregnant, non-lactating Simmental heifers (SM; n = 
12) with a mean BCS of 5.0 were housed in a tie-stall barn bedded with straw at the 
Frankenforst experimental research farm of the Faculty of Agriculture, University of 
Bonn, Germany. The animals were fed with grass silage for ad libitum intake. To 
investigate the effects of a moderate weight loss, the heifers were allocated to 2 groups 
(n = 6 each) of similar mean BW (692 ± 43 kg). One half of the heifers was assigned to 
a ration in which grass silage was blended with a hay/straw mixture (ratio 37:63 on a 
DM basis; n = 6), whereas the other animals remained on the grass silage diet. The grass 
silage contained 10.6% CP, 54.8% NDF (ash-free), and 34.6% ADF (ash-free), and the 
hay/straw-silage mixture contained 8.5% CP, 63.2% NDF (ash-free), and 37.0% ADF 
(ash-free) on a DM basis. The estimated ME concentrations of the grass silage and 
hay/straw mixture were 9.5 and 8.1 MJ/kg of DM, respectively. After 4 wk of 
differential feeding, all animals were fed again with grass silage for further 3 wk. To 
avoid potential effects of divergent stages of estrus cycle, all animals received a 
progesterone-releasing intravaginal device (PRID-alpha, Ceva Sante Animale, 
Libourne, France) that was renewed every third week.  
In addition, to investigate the phagocytic immune cell infiltration in male animal with 
high BW, tailhead fat biopsies (n = 3) were sampled from 13-yr-old, rumen-fistulated, 
fat German Red Pied steers (RP; n = 3), with a mean BW of 1300 kg. The animals were 
housed in a free-stall barn at the Frankenforst experimental research farm of the Faculty 
of Agriculture, University of Bonn, Germany. They had ad libitum access to pasture 
during summer and to medium quality grass silage during winter. 
  
Tissue sample collection and analysis 
 
In trial 1, AT samples from three SC depots (tailhead, withers, and sternum) and from 
three VC depots (omental, mesenteric, and retroperitoneal fat) were collected 
immediately after slaughter. The mesenteric fat was collected from the fat around the 
jejunum and the retroperitoneal fat was sampled from the pararenal fat, located 
superficial to the renal fascia. The AT samples were then dissected and weighed. The 
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empty BW (EBW) was calculated as sum of the weights of all body parts, which were 
recorded during the slaughter process without claws cut off, ingesta and contents of 
urinary and gall bladder. For trial 2, SC tailhead fat samples (n = 36) were collected by 
repeated surgical biopsies (1 samplings at the end of each the consistent grass silage 
feeding, the differing feeding and the refeeding period) from the tailhead area according 
to the methods of Smith and McNamara (1989). In brief, after cleaning and disinfecting 
the sampling area and local lumbar anesthesia with 2% procaine hydrochloride 
(Procasel 2%, Selectavet; Dr. Otto Fischer, Weyarn-Holzolling, Germany), s.c. fat 
biopsy was excised through a 5-cm incision from the base of the tail. Subcutaneous 
tailhead fat biopsies were taken collected from RP steers in the same method. All the 
tissue samples were then cut into small pieces (approximately 1 cm³), rinsed in 0.9% 
sodium chloride and immediately snap frozen in liquid nitrogen. They were transported 
on dry ice to the laboratory and then stored at -80°C until analyses. 
 
Immunohistochemical analyses  
 
Adipose tissue cryosections (14 to 18 µm) were cut on a cryostat (Leica, Wetzlar, 
Germany), mounted on SuperFrost Plus slides (Menzel, Braunschweig, Germany) and 
stored at -20°C until further staining. Frozen tissue sections were fixed in chloroform-
methanol mixture (Applichem, Darmstadt, Germany; 1:1, vol/vol) at room temperature 
(RT) for 4 h, the mixture was stored at -20°C before use. After blocking endogenous 
peroxidase activity with 0.3% hydrogen peroxide (Roth¸ Karlsruhe, Germany) in 
methanol at RT for 15 min, the sections were incubated with normal goat serum at a 
dilution of 1:10 at RT for 20 min to block non-specific binding. The sections were then 
incubated with the primary monoclonal antibodies (mAb) at 4°C overnight, as listed in 
Table 1. The mAb against CD68 was detected by a secondary peroxidase-coupled goat-
anti-mouse antibody (Dako), whereas the mAb against CD14, CD11b, and CD11c were 
detected with a biotinylated secondary goat anti-mouse antibody (Southern Biotech, 
Birmingham, AL) in PBS at a dilution of 1:200 at RT for 30 min. After incubating the 
slides with the biotinylated secondary antibody, the sections were additionally incubated 
with horseradish peroxidase-conjugated streptavidin (Southern Biotech) at a dilution of 
1:1000 (1:1600 for CD14) at RT for 30 min. Antigen-antibody complexes were 
visualized by 3-amino-9-ethylcarbazole (Biozol, Eching, Germany). The sections were 
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counterstained with Mayer's hematoxylin and mounted with Kaiser’s glycerol gelatine 
(both from Merck, Darmstadt, Germany). Bovine lymphnode samples were used as 
positive and negative controls to the entire procedure to test specificity of 
immunostaining. The sections used as negative controls were incubated with PBS 
instead of the primary mAb. 
 
Histoplanimetry 
 
Bright-field pictures were taken from 10 representative fields per sample at 100× 
magnification using a Leica DMLB microscope (Leica Microsystems, Wetzlar, 
Germany) and JVC digital color camera KY-F75U (Hachioji Plant of Victor Company, 
Tokyo, Japan). Adipocyte areas (µm²) were measured as described previously (Akter et 
al., 2011). The numbers of immunopositive cells and adipocytes per mm² were counted 
(10 fields/sample) using a grid (900 × 700 µm) with an image analysis software 
(DISKUS version 4.0; Hilgers, Königswinter, Germany). The portion of CD68+ cells 
for each sample was calculated as the sum of the number of CD68+ cells divided by the 
total number of cells per section and then multiplied by 100. The same procedure was 
used to calculate the portion of CD14+, CD11b+, and CD11c+ immune cells in different 
AT depots. For the CD68 immunostaining, in total 150 samples (from 25 HF cows) 
were tested. However, for the detection of additional CD14, CD11b, and CD11c 
markers in HF cows, six AT samples were taken from two cows per group at 1, 42, and 
105 DIM (n = 60), including 9 CD68+ samples. In addition, these markers were also 
used for the remaining one CD68+ sample belonging to a cow at 1 DIM (in total n = 
61).  
 
Statistical analyses  
 
Data for all variables were tested for normal distribution with the Kolmogorov-Smirnov 
test and for homogeneity of variances with the Levene's test. The Student’s t-test was 
used to analyze the differences between the adipocyte sizes of HF cows and SM heifers; 
differences were considered significant at P < 0.05. Pearson correlation was used to 
examine the relationship between the percentage of CD68+ cells with both EBW and 
Manuscript 2     52
adipocyte size. All analyses were done using SPSS software, version 19.0 (SPSS, Inc., 
Chicago, Illinois). Values are given as means ± SEM. 
 
Results  
 
The hypothesis of the present study was that the portion of phagocytic cells might be 
small in AT of early-lactating dairy cows. To identify and quantify these immune cells 
into AT, sections were immunohistochemically stained by using mAbs against CD68, 
CD14, CD11b, and CD11c. Immunopositive cells were found in only few samples of 
HF cows during the first 105 DIM. Macrophages (CD68+) were immunolocalized as 
uniformly small, isolated cells around the cytoplasm of mature adipocytes. 
Representative pictures of the SC (tailhead) and the VC (mesenteric) fat depots are 
shown in Fig. 1. The same staining patterns were observed for CD14, CD11b, and 
CD11c; however, in contrast to CD68+ staining, most of the positive cells were 
observed in the stromal-vascular fraction (SVF) rather than around adipocytes.  
 
Immune cell infiltration into adipose tissue of early-lactating cows 
 
CD68. CD68 is the main cell surface marker of macrophages. With the exception of 10 
samples from eight cows, no ATM positive staining was observed in the remaining 140 
samples (Table 1). The average portion of CD68+ ATM in the few positive samples was 
slightly but insignificantly lower in SC depot (3.7 ± 0.7%, n = 3) than in VC depot (24.7 
± 5.2%, n = 7).  
 
CD14. CD14 is used as a marker of macrophages and monocytes. The immunostaining 
was positive only in one (out of 61) samples. The portion of CD14+ immune cells was 
2.0% in the SC tailhead depot (Table 1).  
 
CD11b. CD11b is used as a marker of macrophages, monocytes, and granulocytes. The 
immunostaining was positive in eight (out of 61) samples from six cows, among which 
five animals were coincidently immunopositive for CD68 (Table 1). The average 
portions of CD11b+ immune cells in the positive samples were 1.9 ± 0.6% (n = 3) and 
1.6 ± 0.7% (n = 5) in SC and VC depots, respectively.  
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CD11c. CD11c is commonly used as a marker of macrophages and monocytes. With the 
exception of two samples from one cow, no CD11c positive staining was observed in 
the remaining 59 samples. The average portion of CD11c+ immune cells in the positive 
samples was 3.7 ± 1.7% (n = 2). The SC depot from tailhead and sternum, but not the 
VC depot showed positive signal for this marker. These two samples were also 
immunopositive for CD68.  
 
Effects of lactation time and CLA supplementation on the invasion of immune cells 
into adipose tissue 
 
A total of nine animals showed positive immunostainings in a few positive AT depots, 
irrespective of DIM and CLA supplementation (Table 1). No positive staining was 
found in any of the SC depots of CON cows at 1 DIM. For the visceral depots, positive 
staining both for the CD68 and the CD11b markers were detected coincidently in 
omental and mesenteric fat in two CON cows of 1 DIM. At 42 DIM, two CD68+ 
samples were found both in the SC withers depot and in the omental fat from the same 
CON cow. At 105 DIM, one positive CD68 staining in the retroperitoneal fat and three 
positive CD11b immunostainings in the SC fat from withers and sternum as well as in 
the retroperitoneal fat were observed from the same CON cow. Considering CLA 
supplementation, four positive immunostainings for the CD68, CD14, CD11b, and 
CD11c markers in the SC tailhead depot and two positive immunostainings for the 
CD68 and CD11c markers in the SC sternum depot were detected coincidently in the 
same CLA fed cow at 42 DIM. However, no differences with regard to either DIM or 
CLA supplementation were observed in the few positive samples for all the 
immunostainings.  
 
Comparison of the portion of phagocytic immune cells in adipose tissues from early-
lactating cows, non-pregnant, over-conditioned heifers, and fat steers   
 
We herein found that the average portions of ATM (CD68+) in the SC tailhead depot 
were only marginal both in non-pregnant SM heifers and the early-lactating HF cows 
(Table 3), although the adipocyte size of this depot was larger in SM heifers than in HF 
cows (P < 0.001), with mean areas of 8,230 ± 240 µm² and 5,146 ± 491 µm², 
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respectively. However, no significant effect of differential feeding was observed in the 
SM heifers. The portion of CD68 positive samples (SC tailhead) in the SM heifers 
(64%, i.e., 23 out of 36 samples) was 16 times higher than in the corresponding depots 
from the HF cows (4%; i.e., 1 out of 25 samples). Moreover, only 10% of the samples 
showed positive signals for each of the CD14, CD11b, and CD11c markers in HF cows, 
whereas they were 47, 33, and 58%, respectively in SM heifers (Table 3). In fat RP 
steers, no CD68 and CD11c positive staining were observed in the SC fat, whereas the 
portions of CD14+ and CD11b+ samples were 100 and 33%, respectively.  
 
Correlations between the portion of ATM (CD68+) with EBW and adipocyte size 
 
To investigate the relationship between the portion of ATM (CD68+) in positive 
samples with EBW and adipocyte size, we calculated the correlations. Strong positive 
correlations were found between the portion of ATM with both EBW (r = 0.788, P = 
0.007, n = 10) and mean adipocyte area (r = 0.684, P = 0.029, n = 10). Data collected 
from the 10 positive samples out of 150 analyzed, are shown in Fig. 2. Some samples 
comprising large adipocytes still did not show positive signal for CD68 marker. 
However, no significant relationships were detectable between the portion of ATM and 
adipocyte size in SC tailhead depots from the SM heifers.   
 
Discussion 
 
In the present study, different fat depots of dairy cows were characterized in terms of 
the number of phagocytic immune cells present. In this context, metabolic adaptations 
to early lactation and dietary CLA related changes were of particular interest. For 
identifying phagocytic immune cells in AT, we used mAbs directed against CD markers 
i.e., CD68, CD14, CD11b, and CD11c that are surface markers for monocytes, 
macrophages, and granulocytes (neutrophils). We herein present immunohistochemical 
evidence against an appreciable infiltration of phagocytic immune cells in bovine SC 
and VC fat depots. Several previous reports have been presented with regard to the 
localization and distribution of such cells in AT of obese mice and humans by using 
various mAbs (Weisberg et al., 2003; Xu et al., 2003; Curat et al., 2004; Cinti et al., 
2005; Elgazar-Carmon et al., 2008). In the context of obesity and high-fat diet, 
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macrophages are one of the most prominent infiltrating cell types into AT. Most 
research on ATM infiltration in monogastric species is limited to obese individuals; 
however, early-lactating cows are not ‘obese’ and may thus lack significant infiltration 
of macrophages into different AT depots.  
We herein characterized specific immunohistological features of infiltrating 
macrophages in different bovine AT depots. In early-lactating cows, the sparsely 
observed CD68+ macrophages were mostly localized around mature adipocytes. They 
probably correspond to the number of resident ATM that may eventually respond to 
local inflammation. This finding is similar to the study of infiltrating macrophages into 
the SC fat in lean humans (Cancello et al., 2005). The ATM of early-lactating cows 
were uniformly small, isolated, and dispersed among the adipocytes. This observation 
agrees with the study of infiltrating macrophages into the SC fat of lean mice (Weisberg 
et al., 2003). In contrast, ATM localize to crown-like structures around individual 
adipocytes in VC fat both in lean and obese mice, which increase in frequency with 
obesity (Cinti et al., 2005). These structures were also found within the SC and VC fat 
in human obese patients, but were less frequent than in mice (Cancello et al., 2005; 
Zeyda et al., 2007).  
 
Evidence against an appreciable infiltration of phagocytic immune cells into bovine 
adipose tissue during early lactation 
 
It is well known that metabolic adaptations in bovine AT form a critical part in 
establishing and maintaining lactation (Smith and McNamara, 1990; McNamara, 2010). 
During early lactation, the state of NEB contributes to the immunocompromised 
situation in dairy cows, and thus leads to increased susceptibility to infectious diseases. 
In the present study, a low incidence of infiltrating phagocytic immune cells was 
observed in different fat depots of primiparous dairy cows during the first 105 DIM. We 
herein found that the portion of the CD68 positive samples was 6.6% in HF cows. 
Although CD68 is the main cell surface marker for macrophages, some other additional 
known macrophage markers have been reported to be expressed on monocytes (CD14; 
CD11b; CD11c) or on granulocytes (CD11b). Therefore, CD14, CD11b, and CD11c 
markers were combined in the present study and the portions of positive samples were 
1.6, 13, and 3.3%, respectively. Weisberg et al. (2003) estimated that the portion of 
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ATM ranges from under 10% in lean mice to over 50% in extremely obese, leptin-
deficient mice, where AT depots from all mice contained F4/80 expressing cells 
(macrophages). However, in the present study, only 32% of the early-lactating HF cows 
showed marginal infiltration of CD68+ ATM in different fat depots, irrespective of 
DIM and CLA supplementation.  
In the present study, the average portion of CD68+ ATM was numerically higher in VC 
than in SC depot, which is in agreement with other studies in obese mice (Weisberg et 
al., 2003) and humans (Tchoukalova et al., 2004; Harman-Boehm et al., 2007). This 
may be due to the fact that VC fat is more metabolically active and is thought to differ 
from SC fat in terms of adipokine production (Altomonte et al., 2003). Several other 
authors have suggested that the differences in the local production of chemokines may 
account for such a discrepancy (Takahashi et al., 2003; Bruun et al., 2004; Skurk et al., 
2005). This is in line with the view that adipocytes found in different depots have 
different properties (Wajchenberg et al., 2002; Cartwright et al., 2007). However, herein 
we did not observe any effect of DIM on the invasion of phagocytic immune cells into 
bovine AT (Table 2).  
Immunohistochemical analyses of different SC and VC fat depots revealed that the 
portion of CD68+ ATM (from 10 positive samples out of 150 analyzed) was positively 
correlated with both EBW and adipocyte size. The positive linear correlation found 
between adipocyte size and CD68+ ATM suggests that large adipocyte size probably 
triggers macrophage infiltration. However, macrophage motility is characterized by its 
ability to respond to chemokine gradients emanating from AT (Gruen et al., 2007; 
described in the next section). In mice, ATM content in SC, perigonadal, perirenal, and 
mesenteric depots correlates positively with criteria for adiposity such as body mass 
index, percent body fat and adipocyte size (Weisberg et al., 2003). A similar positive 
correlation has been observed between ATM content in human SC fat depot and 
adiposity (Curat et al., 2004).  
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Mechanisms of infiltration of phagocytic immune cells into adipose tissue  
 
The mechanism behind the migration of phagocytic immune cells into AT is not well 
clarified. It is thought that with the expansion of AT during weight gain, induction of a 
range of signaling pathways activates the adipose SVF, allowing monocytes to 
extravasate through the endothelial cell layer into the AT where they differentiate into 
macrophages. These macrophages localize predominantly around dead adipocytes 
(Neels and Olefsky, 2006). Several reports suggest that the diverse biological activity of 
macrophage is mediated by functionally distinct subpopulations that are phenotypically 
polarized by their microenvironment and by exposure to inflammatory mediators. These 
divergent ATM subpopulations are broadly classified into two major groups: classically 
activated M1-type and alternatively activated M2-type macrophages. M1-types are 
induced by inflammatory agents, whereas M2-types are induced by IL-4 and IL-13 
(Lumeng et al., 2007; Zeyda et al., 2007; Bourlier et al., 2008). M1-type macrophages 
display a cytotoxic, proinflammatory phenotype, whereas M2-type macrophages 
suppress immune and inflammatory responses and participate in wound repair and 
angiogenesis (Laskin, 2009). The ATM phenotypically resemble the antiinflammatory 
M2-type of macrophages in humans and mice (Zeyda and Stulnig, 2007). The changes 
in the expression of pro- and anti-inflammatory factors after weight loss in obese 
individuals have been associated with a shift in the activation type of the tissue resident 
macrophages from the M1-type to M2-type macrophages (Clément et al., 2004). 
However, metabolic changes of AT in obesity may stimulate the chemokines 
production, contributing to macrophage infiltration into AT (Wellen and Hotamisligil, 
2005). On a quantitative basis, the vast majority of these chemokines come from the 
SVF of AT (Fain, 2006). For example, ATM produce the majority of TNF-α in AT, 
when compared to adipocytes or other cells in the SVF (Weisberg et al., 2003) and 
TNF-α expression increases with obesity (Hostamisligil et al., 1993). In SC fat of dairy 
cows, the mRNA abundance of TNF-α is higher at 1 DIM and at week 5 postpartum, 
compared with week 8 antepartum (Sadri et al., 2010).  
Surface marker characteristics of ATM are important for their quantification. Most 
experimental data on AT inflammation originate from mouse experiments and in 
general F4/80-expressing cells in AT are referred to as ATM. Murine ATM have been 
shown to be CD14 negative and CD11c has been found particularly as a marker for diet-
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induced obesity-associated inflammatory macrophages (M1-type) in murine AT 
(Lumeng et al., 2006), whereas CD206, CD209, and CD163 are well known M2 
markers (Mantovani et al., 2002; Gordon and Taylor, 2005). Human ATM differs from 
murine ATM by expressing CD14; however, CD11c is only poorly expressed on human 
ATM (Curat et al., 2004; Zeyda et al., 2007). In the present study, 58% samples 
showing positive signals for CD11c in SC fat of non-pregnant, over-conditioned SM 
heifers, might represent the M1-type of macrophages. 
In our previous report (Akter et al., 2011), we demonstrated that the experimental HF 
cows experiencing NEB at first sampling on 1 DIM, but were returned to positive 
energy balance at the day of second slaughter series i.e., 42 DIM irrespective of CLA 
supplementation. During early lactation, the state of NEB results in increased plasma 
concentrations of both NEFA and BHBA which in turn exert inhibitory effects on 
leukocytes and thus contribute to the immunocompromised situation in ewes and dairy 
heifers (Lacetera et al., 2002, 2004). The portions of CD68+, CD14+, CD11b+, and 
CD11c+ samples in SM heifers were consistently higher than in samples from HF cows 
(Table 3). The present data suggest that the increased accumulation of CD68+, CD14+, 
CD11b+, and CD11c+ cells, albeit at low cell numbers, in SM heifers could be related 
to large adipocytes secreting higher amounts of chemoattractant adipokines. In this 
context, several reports showed that AT production of monocyte chemoattractant 
protein-1, a chemoattractant specific for monocytes and macrophages is increased in 
obese, leptin-deficient mice compared with lean mice (Lu et al., 1998; Sartipy and 
Loskutoff, 2003). Moreover, leptin is secreted exclusively by adipocytes and is capable 
of linking metabolism and immune homeostasis (Matarese and La Cava, 2004). It has 
been reported to be also a chemoattractant for neutrophils (Ottonello et al., 2004) as 
well as for monocytes and macrophages (Gruen et al., 2007). In our present study, the 
larger adipocyte size of SC tailhead fat that we observed in SM heifers was associated 
with higher concentration of plasma leptin (data not shown) compared with HF cows. 
However, plasma leptin concentrations may reflect increased overall secretion, but they 
do not provide detailed information regarding local concentration gradients formed in 
AT. For example, leptin is a chemoattractant at concentrations as low as 1 pg/ml, with 
maximal effects at 1 ng/ml. However chemotaxis tended to decline at concentration of 
10 and 100 ng/ml (Gruen et al., 2007). Our data also indicate that in fat RP steers, the 
portions of CD14 and CD11b positive samples were higher than the HF cows, although 
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no CD68 and CD11c positive staining were observed in the SC fat in fat RP steers 
(Table 3). Possible reasons for this difference might be due to sex hormone differences 
immanent in the comparison of intact females versus male long-term castrates. 
Comparing intact male and female mice, Weisberg et al. (2003) reported that the portion 
of mature F4/80-expressing macrophages was slightly lower for the SC fat of males 
regardless of body condition. 
 
Effects of CLA on the invasion of phagocytic immune cells into bovine adipose tissue  
 
In the present study, 4 positive immunostainings for the CD68, CD14, CD11b, and 
CD11c were detected coincidently in the same tissue (SC tailhead) and in the same CLA 
fed HF cow at 42 DIM. The same animal showed positive staining for the CD68 and 
CD11c in the SC depot from sternum at 42 DIM (Table 2). Although we hypothesized 
that in bovine AT, phagocytic immune cell infiltration might be affected by dietary 
CLA supplementation, no obvious differences with regard to the CLA supplementation 
were observed in HF cows.  
Several authors reported that the t10,c12 isomer promotes ATM infiltration and 
decreases leptin and adiponectin secretion, which in turn contributes to insulin 
resistance and hyperinsulinemia in CLA-fed humans and animals (Pérez-Matute et al., 
2007; Clément et al., 2002; Poirier et al., 2006). The t10,c12 isomer rapidly induced 
inflammatory factors, such as TNF-α and IL-6 in AT (Ahn et al., 2006, Poirier et al., 
2006). In vitro studies with 3T3-L1 and human adipocytes have also shown that the 
t10,c12 isomer directly stimulates IL-6 secretion via a nuclear factor-kappa B-
dependent mechanism (Poirier et al., 2006). In contrast, supplementation with c9,t11 
isomer results in low ATM infiltration with concomitant decrease in inflammatory 
cytokines, which may in turn improve insulin sensitivity in mice (Moloney et al., 2007). 
However, the present study did not focus on the individual CLA isomer, but tested 
mixture at a ratio of 50:50 for the main c9,t11 and t10,c12 isomers. 
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Conclusions 
 
The portion of phagocytic immune cells both in SC and VC fat depots was marginal in 
early-lactating cows. The average portion of ATM (CD68+) in few positive samples 
was slightly lower in SC versus VC fat depots. No significant alterations in this 
infiltration phenomenon, with regards to DIM and CLA supplementation were observed 
during early lactation. Increased accumulation of phagocytic immune cells, albeit at low 
cell numbers, in non-pregnant, over-conditioned heifers could be related to larger 
adipocytes compared with the early-lactating cows. Based on the small portion of 
positive samples, we concluded that the extent of fatness in early-lactating dairy cows 
may not be high enough to stimulate significant infiltration of phagocytic cells and 
therefore, these immune cells might have no major role in the immunologic and 
metabolic adaptations during early lactation.  
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Table 1: Primary mouse monoclonal antibodies used in this study 
 
Targets  Clones Sources Dilutions Specificity References 
CD68 
(human) 
EBM11 DakoCytomation, 
Glostrup, 
Denmark 
1:100 Macrophages Bielefeldt-Ohmann et al., 
1988 
CD14 
(bovine) 
CAM36A VMRD, Pullman, 
WA., USA) 
1:100 Macrophages, 
monocytes 
Miyazawa et al., 2006 
CD11b 
(canine) 
CA16.3E
10 
Biozol, Eching, 
Germany 
1:25 Macrophages, 
monocytes, 
granulocytes 
Danilenko et al., 1992. 
CD11c 
(bovine) 
BAQ153
A 
VMRD 1:25 Macrophages, 
monocytes, 
Miyazawa et al., 2006 
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Table 2: Portion (%) of positive cells expressing CD68, CD14, CD11b, and CD11c 
markers in different fat depots of Holstein cows during the first 105 DIM 
(to allow for tracing back individual positive sample, respective individual 
animal identification numbers are given in brackets) 
 
Item Markers 1 DIM 42 DIM 105 DIM 
Control group (n = 15)     
Subcutaneous (SC) depots     
Tailhead 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 Withers 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
- 
- 
- 
- 
 
4.5 (657) 
- 
- 
- 
 
- 
- 
1.8 (647) 
- 
 Sternum 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0.7 (647) 
- 
Visceral (VC) depots     
Omental 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
14.3 (635) 
- 
0.7 (635), 4.7 (664) 
- 
 
12.8 (657) 
- 
- 
- 
 
- 
- 
- 
- 
 Mesenteric 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
41.6 (619), 27.2 (664) 
- 
0.4 (664) 
- 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 Retroperitoneal 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
- 
- 
- 
- 
- 
- 
- 
- 
46.8 (647) 
- 
0.8 (640), 1.5 (647) 
- 
Conjugated linoleic acid group  
(n = 10)  
 
   
SC depots     
Tailhead 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
 
2.0 (668) 
2.0 (668) 
3.3 (668) 
1.2 (668) 
- 
- 
- 
- 
 Withers 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 Sternum 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c: 
 
4.7 (668) 
- 
- 
6.3 (668) 
- 
- 
- 
- 
VC depots     
Omental 
 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
 
- 
- 
- 
- 
 
7.2 (655) 
- 
- 
- 
Mesenteric 
 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 Retroperitoneal 
 
 
 
 
CD68: 
CD14:  
CD11b:  
CD11c:  
 
 23.2 (666) 
- 
- 
- 
 
- 
- 
- 
- 
 
Manuscript 2     70
Table 3: Portion (%) of immune cells in the subcutaneous tailhead fat in 
early-lactating primiparous (HF) cows, non-pregnant, over-
conditioned (SM) heifers and in fat steers (RP) (means ± SEM) 
*Indicates the tissue sample coincidently from same animal (ear tag 668) 
†Indicates n = 10 from early-lactating HF cows were tested. 
n = number of samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item  CD68 CD14 CD11b CD11c 
HF cows (n = 25) 2.0 (n = 1)* 2.0 (n = 1)*† 3.3 (n = 1)*† 1.2 (n = 1)*† 
SM heifers (n = 36)   1.9 ± 0.4 (n = 23) 1.7 ± 0.4 (n = 17) 2.2 ± 0.6 (n = 12) 2.1± 0.7 (n = 21) 
RP steers (n = 3) -     2.5 ± 0.8 (n = 3)         2.1 (n = 1) - 
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Fig. 1:  Immunohistochemical localization of adipose tissue macrophages in 
subcutaneous (SC) fat from the tailhead and visceral (VC) fat from 
the mesenteric depot in early-lactating cows, using antibody against 
CD68. Representative positive cells (arrows designate examples) appear 
as red staining around mature adipocytes. Macrophages were more 
frequent in mesenteric fat than in the SC tailhead depot. Original 
magnification 200×; Scale bar = 100 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SC fat (Tailhead)  
 
VC fat (Mesenteric)  
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Fig. 2: Correlations between the portion of CD68+ cells with (a) empty body 
weight (EBW) and (b) adipocyte size. Strong positive correlations were 
found between the portion of CD68+ cells with both EBW (r = 0.788, P 
= 0.007, n = 10) and mean adipocyte area (r = 0.684, P = 0.029, n = 10). 
Data included herein were collected from all positive immunostained 
samples of early-lactating Holstein-Friesian cows.  
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4  General discussion and conclusions 
 
The present research was carried out to compare different SC and VC fat depots of dairy 
cows in terms of adipocyte size and number of phagocytic immune cells present. 
Furthermore, the effects of CLA on adipocyte size and on the invasion of phagocytic 
immune cells in different fat depots were investigated in dairy cows up to the first 105 
DIM. This is the first report on the effects of CLA on bovine AT cellularity. Herein, we 
consider potential changes within AT and put it into relation with concomitant changes 
in the entire organism during early lactation.  
Early lactation is attended by massive fat mobilization. In the present study, the 
concomitant changes of adipocyte size were non-uniform in different SC and VC fat 
depots during early lactation. For CON animals, adipocyte sizes were decreased at 42 
and 105 DIM compared to 1 DIM in almost all the SC and VC fat depots examined, but 
the decrease in the retroperitoneal fat only tended to be significant at 105 DIM. Previous 
studies on the cellularity of bovine AT have reported a decrease in the mean adipocyte 
size of the SC fat during early lactation (Pike and Roberts, 1980, 1981). The present 
study confirms the cellularity changes found in these previous reports and further 
characterizes cellularity variable in different anatomical locations of SC and VC fat up 
to 105 DIM. Moreover, in a companion study (von Soosten et al., 2011), the authors 
found that the retroperitoneal fat depot weight for CON animals was significantly 
decreased at 42 DIM and numerically decreased at 105 DIM compared to 1 DIM. 
Combining the results from this study with that reported in the aforementioned 
companion study, we herein confirm that the retroperitoneal fat might have undergone 
the greatest changes during early lactation. In the same study, von Soosten et al. also 
reported that supplementation of dairy cows with CLA decreases milk fat but leaves 
body fat mostly unaffected in terms of depot mass. However, when considering 
adipocyte sizes of different SC and VC fat depots of dairy cows, we herein observed 
decreasing effects of CLA up to 105 DIM, albeit these alterations were not mirrored by 
the plasma NEFA concentrations. However, the positive correlation between adipocyte 
size and plasma BHBA, indicate that the processes of lipolysis might be increased in 
AT in a depot-specific manner both in CON and CLA supplemented cows. We hereby 
speculate that the CLA-induced decreases in adipocyte size may indicate lipolytic 
and/or antilipogenic effects of CLA on AT in primiparous dairy cows.  
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Human and mouse studies suggest that increased body fat mass is associated with 
increased infiltration of ATM, and induces AT inflammation and insulin resistance 
(Weisberg et al., 2003; Xu et al., 2003). However, during early lactation, the state of 
NEB provides more plasma NEFA and BHBA that exert inhibitory effects on 
leukocytes and thus contribute to the immunocompromised situation in ewes and dairy 
heifers (Lacetera et al., 2002, 2004). We herein present immunohistochemical evidence 
against an appreciable infiltration of phagocytic immune cells into different AT depots 
of dairy cows during early lactation. The average portion of ATM (CD68+) in a few 
positive samples was numerically lower in SC versus VC fat depot. This may be due to 
the fact that VC fat is more metabolically active and is thought to differ from SC fat in 
the production of adipokines (Altomonte et al., 2003). In addition, increased 
accumulation of phagocytic immune cells (albeit at low cell numbers) in SC fat of non-
pregnant, over-conditioned heifers might be related to larger adipocytes secreting higher 
amounts of chemoattractant adipokines compared with the early-lactating cows.  
In conclusion, dietary CLA supplements have site-specific effects on adipocyte size of 
different fat depots in dairy cows. The results suggest that dairy cows respond to CLA 
in terms of a decrease in adipocyte size in the same way as other monogastric species 
such as rodents and pigs. The present data also suggest that CLA had no effect on the 
invasion of phagocytic immune cells in bovine AT.  Early-lactating dairy cows are not 
‘obese’ and may thus lack significant infiltration of phagocytic cells in bovine AT.  
Therefore these immune cells might have no major role in the immunologic and 
metabolic adaptations during early lactation. However, the present study did not focus 
on individual CLA isomers, since a mixture at a ratio of 50:50 c9,t11 and t10,c12, the 
two major isomers, was used as feed supplement. Further research is required on the 
action of individual c9,t11 and t10,c12 isomers in order to better understand and 
evaluate their physiological effects on body fat depots in dairy cows. Moreover, recent 
study put in evidence a clear effect of CLA on the differentiation of bovine 
preadipocytes (Lengi and Corl, 2010). Therefore, another line of investigation should 
focus on characterizing bovine AT in terms of the number and size of preadipocytes. 
Furthermore, typization of ATM subpopulations would be potentially interesting for 
further research. 
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5  Summary 
 
High-yielding dairy cows experience a period of NEB during early lactation and are 
then susceptible to metabolic disorders, compromised immune response and fertility. 
Dietary intake at this period lags behind the increase of nutrient needs; therefore energy 
has to be mobilized from body reserves mainly from the WAT. Nevertheless, WAT is 
not a functionally homogeneous tissue; rather, it consists of different depots with 
considerable functional and morphologic differences. Besides its main function as an 
energy storage depot, WAT is currently considered as an endocrine organ capable of 
producing and secreting adipokines. The adipose-derived hormones affect a wide range 
of different processes including appetite regulation, glucose metabolism, insulin 
sensitivity, lipid metabolism, inflammation, and immune functions. In the context of 
obesity and high-fat diet, humans and mice exhibit increased infiltration of ATM, 
particularly in VC depots to form a proinflammatory micromilieu causing local and 
systemic insulin resistance. However, the metabolic stress situation in early-lactating 
dairy cows is similar to some symptoms observed in obese individuals suffering from 
metabolic syndrome, for example, decreased insulin sensitivity in peripheral tissues. 
Furthermore, the state of NEB elicits increased release of plasma NEFA and BHBA that 
exert inhibitory effects on leukocytes and thus contribute to the immunocompromised 
situation in early lactation, leading to increased susceptibility to infectious diseases. To 
our knowledge, no reports exist about body fat-decreasing effects of CLA in dairy cows. 
Moreover, evidences for phagocytic immune cell infiltration into bovine AT, in 
particular addressing the heterogeneity of SC versus VC fat depots are lacking. 
Conjugated linoleic acid, a naturally occurring fatty acid, derived from beef and dairy 
products has been found to decrease milk fat excretion in lactating animals. Dietary 
CLA supplements also decrease body fat mass in several monogastric species, such as 
rodents and pigs. Herein, we hypothesized that dietary CLA supplements have site-
specific effects on adipocyte size of different fat depots in dairy cows, with regards to 
the concomitant changes during early lactation. It was also hypothesized that low 
incidence of AT phagocytic immune cell infiltration might occur in early-lactating dairy 
cows, since they are certainly not ‘obese’. Therefore, the experiments conducted herein 
were aimed: 1) to characterize different SC and VC fat depots of dairy cows in terms of 
adipocyte size, 2) to investigate phagocytic immune cell infiltration in bovine AT, 3) to 
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evaluate the effects of CLA on adipocyte size of different fat depots in dairy cows 
during the first 105 DIM, and 4) to investigate the potential effects of CLA on the 
invasion of phagocytic immune cells into bovine AT.  
German Holstein cows (n = 25; mean BCS = 3.0) were randomly allocated to either the 
CON (n = 15) or the CLA (n = 10) group. From the first DIM until sample collection, 
the CLA cows were fed 100 g of CLA/d (containing about 6% each of the c9,t11 and 
t10,c12 isomers), whereas CON cows received 100 g/d of a fatty acid mixture without 
CLA. The CON cows (n = 5 each) were slaughtered at 1, 42, and 105 DIM, and the 
CLA cows (n = 5 each) were slaughtered at 42 and 105 DIM. Adipose tissues (n = 150) 
from three SC depots (tailhead, withers, and sternum) and from three VC depots 
(omental, mesenteric, and retroperitoneal) were sampled. In addition, SC tailhead AT 
samples were collected by repeated surgical biopsies (3 samplings within 7 weeks, n = 
36) from non-pregnant, non-lactating Simmental heifers (n = 12; mean BCS = 5.0) fed 
diets of varying energy density. Hematoxylin-eosin staining was done on 10-µm-thick 
paraffin-embedded tissue sections (n = 150). Adipocyte area (µm²) of 100 adipocytes 
per section was measured at magnification 100×. Immunohistochemistry was used to 
quantify CD68, CD14, CD11b, and CD11c positive cells on AT cryosections (14 to 18 
µm). The portion of immunopositive cells per sample was calculated as the sum of the 
number of immunopositive cells divided by the total number of cells per section and 
then multiplied by 100 (magnification 100×, 10 fields/sample).  
We herein demonstrated that significant changes related to duration of lactation were 
limited to retroperitoneal fat: adipocyte sizes were significantly smaller at 105 DIM 
compared to 1 DIM in CON cows. Adipocyte sizes were decreased in SC depots from 
the tailhead at 105 DIM and from the sternum at 42 DIM in CLA versus CON cows, 
whereas for VC depots adipocyte sizes were decreased in mesenteric fat at 42 and 105 
DIM, and in omental and retroperitoneal fat at 105 DIM in CLA versus CON cows. 
Within the CLA group, adipocyte sizes were smaller in the SC depot from the tailhead 
at 105 DIM compared to 42 DIM. Adipocyte sizes and depot weights were significantly 
correlated in SC depot (r = 0.795, P < 0.01) in the CLA group and in retroperitoneal fat 
both in the CON (r = 0.698, P < 0.01) and the CLA (r = 0.723, P < 0.05) group. The 
present long-term study suggested for the first time that dietary CLA supplements 
decrease adipocyte sizes of both SC and VC fat depots to different extent in dairy cows. 
Moreover, the positive correlation between adipocyte size and plasma BHBA, 
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suggesting that the processes of lipolysis might be increased in AT in a depot-specific 
manner both in CON and in CLA supplemented cows. The results indicated that CLA 
might have lipolytic and/or anti-lipogenic effects on bovine AT, similar to what is 
known from CLA supplemented monogastrics. However, immunohistochemical 
analyses of different fat depots revealed a low incidence of phagocytic immune cell 
infiltration in early-lactating cows. The average portion of ATM (CD68+) in a few 
positive samples was slightly but nonsignificantly higher in VC versus SC fat. In 
addition, increased accumulation of phagocytic immune cells (albeit at low cell 
numbers) in SC fat of non-pregnant, over-conditioned heifers might be related to larger 
adipocyte size secreting higher amounts of chemoattractant adipokines compared with 
the early-lactating cows. The results indicated that the extent of fatness in early-
lactating cows may not be high enough to stimulate significant infiltration of phagocytic 
cells. Therefore, these immune cells might have no importance for the immunologic and 
metabolic adaptations during early lactation in dairy cows. The present data also 
suggested that CLA had no effect on the invasion of these cells into bovine AT. 
The results are of general importance to Animal Science and provide a general basis for 
the regulatory role of AT in ruminants. The present dissertation also contributes to 
improve the knowledge about the long-term effects of dietary CLA supplements on 
body fat depots in dairy cows. Further research on the effects of individual c9,t11 and 
t10,c12 isomers on body fat depots of dairy cows should be carried out. Since dietary 
CLA supplementation has effects on bovine preadipocytes differentiation, another line 
of investigation should focus on characterizing bovine AT in terms of the number and 
size of preadipocytes. Furthermore, typization of ATM subpopulations would be 
potentially interesting for further research. 
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6  Zusammenfassung  
 
 
Während der Frühlaktation kommt es bei hochleistenden Milchkühen zu einer Phase der 
NEB, in der sie für Stoffwechselerkrankungen anfällig und sowohl die Immunantwort 
als auch die Fruchtbarkeit eingeschränkt sind. Der erhöhte Energiebedarf kann nicht 
durch die Futteraufnahme ausgleichen werden, sondern wird durch die Mobilisierung 
von Körperfettreserven, vor allem dem weißen Fettgewebe (WAT), kompensiert. Das 
WAT besteht aus verschiedenen Depots mit erheblichen funktionellen und 
morphologischen Unterschieden. Neben seiner Hauptfunktion als Energiespeicher, ist 
das WAT als endokrines Organ angesehen, das Adipokine produziert und sekretiert. Die 
aus dem Fettgewebe stammenden Hormone beeinflussen verschiedene Prozesse wie 
z.B. Appetit, Glukosestoffwechsel, Insulinsensitivität, Fettstoffwechsel, 
Entzündungsprozesse und Immunfunktionen. Bei Übergewicht sowie einer fettreichen 
Diät, weisen Menschen und Nager eine erhöhte Infiltration von Makrophagen (ATM) 
vor allem ins VC Fettgewebe auf, was zur Ausbildung eines  proinflammatorischen 
Mikromilieus und einer lokalen und  systemischen Insulinresistenz führt. Einige 
Symptome, die während der Stoffwechsel-belastenden Situation bei Kühen während der 
Frühlaktation auftreten, ähneln denen des metabolischen Syndroms, beispielsweise die 
verringerte Insulinsensitivität in peripheren Geweben. Des Weiteren kommt es während 
der NEB zu einer erhöhten Freisetzung von Plasma-NEFA und -BHBA, wodurch die 
Leukozytenbildung gehemmt wird, was schließlich zu einem verschlechterten 
Immunstatus in der Frühlaktation beiträgt. Die Anfälligkeit für Infektionskrankheiten 
wird dadurch erhöht. Bislang sind keine Studien über die Körperfett reduzierenden 
Effekte von CLA bei Milchkühen bekannt. Des Weiteren fehlen Nachweise über die 
Infiltration phagozytierender Immunzellen in das bovine AT, insbesondere  bezüglich 
der Unterschiede zwischen SC zu VC Fettdepots.  
Konjugierte Linolsäuren, die natürlicherweise in Fleisch- und Milchprodukten 
vorkommen, reduzieren die Milchfettexkretion bei laktierenden Tieren. Daneben 
reduzieren CLA-Supplemente die Körperfettmasse bei verschiedenen Monogastriern, 
z.B. bei Nagetieren und Schweinen. Dies führte zu der Annahme, dass CLA-
Supplemente während der Frühlaktation gewebsspezifische Effekte auf die 
Adipozytengröße in verschiedenen Fettdepots von Milchkühen vermitteln. Außerdem 
nahmen wir an, dass eine geringe Infiltration phagozytierende Immunzellen in das AT 
bei frühlaktierenden Milchkühen auftritt, da diese nicht „übergewichtig“ sind. Daher 
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hatte die vorliegende Arbeit folgende Ziele: 1) die Adipozytengröße in den 
verschiedenen SC und VC Fettdepots bei Milchkühen zu charakterisieren, 2) den 
Einfluss von CLA auf die Adipozytengröße verschiedener Fettdepots von Milchkühen 
während der ersten 105 Tage der Laktation zu evaluieren, 3) die Infiltration 
phagozytierender Immunzellen in das bovine AT zu untersuchen, 4) die möglichen 
Effekte von CLA auf die Infiltration phagozytierender Immunzellen in das bovine AT 
zu ermitteln. 
Deutsche Holstein Kühe (n = 25; mittlerer BCS = 3,0) wurden zufällig einer CON (n = 
15) und einer CLA (n = 10) Gruppe zugeteilt. Ab dem ersten Laktationstag bis zur 
Probenahme wurden die CLA-Kühe mit 100 g CLA/Tag (mit je 6% c9,t11- und 
t10,c12-Isomer) gefüttert, während die CON-Kühe 100 g/Tag eines Fettsäuregemisches 
ohne CLA erhielten. An Tag 1, 42 und 105 der Laktation wurden je fünf CON-Tiere 
geschlachtet. Die CLA-Tiere (n = 5) wurden an Tag 42 und 105 der Laktation 
geschlachtet. Es wurden Gewebeproben (n = 150)  aus 3 SC (Schwanzansatz, Widerrist, 
Brust) und 3 VC Fettdepots (omental, mesenteric, retroperitoneal) entnommen. 
Zusätzlich wurden wiederholt chirurgische Biopsien (3 Probenahmen innerhalb von 
sieben Wochen, n = 36) von SC Fettgewebsproben aus der Region des Schwanzansatzes 
von nicht-trächtigen, nicht-laktierenden Fleckvieh-Färsen (n = 12; mittlerer BCS = 5,0), 
deren Futter unterschiedliche Energiedichten aufwiesen, entnommen. Paraffinschnitte 
(10 µm, n = 150) wurden mit Hämatoxylin-Eosin gefärbt. Die Adipozytengröße (µm²) 
von 100 Adipozyten je Schnitt wurde bei 100-facher Vergrößerung ausgezählt. Mittels 
Immunhistochemie wurde die Anzahl positiver CD68, CD14, CD11b, CD11c Zellen auf 
AT Gefrierschnitten (14 bis 18 µm) bestimmt. Der prozentuale Anteil positiver Zellen 
wurde aus der Summe der immunpositiven Zellen auf die Gesamtzellzahl pro Schnitt 
bezogen und mit dem Faktor 100 multipliziert (100-fache Vergrößerung, 10 Ausschnitte 
pro Probe).  
Signifikante Unterschiede bezüglich des Laktationsverlaufes waren auf das 
retroperitoneale Fett begrenzt waren: die Adipozytengröße war bei den CON-Tieren an 
Tag 105 der Laktation im Vergleich zu Tag 1 der Laktation signifikant kleiner. Die 
Adipozytengröße in SC Schwanzfettproben an Tag 105 der Laktation und dem Brustfett 
an Tag 42 der Laktation waren bei CLA-Tieren im Vergleich zu den CON-Tieren 
verringert. Im VC Depot war die Adipozytengröße im mesenterialen Fett an Tag 42 und 
105 der Laktation, sowie im omentalen und retroperitonealen Fett an Tag 105 der 
Laktation in den CLA-Tieren im Vergleich zu den CON-Tieren verringert. Innerhalb 
Zusammenfassung  80
der CLA-Gruppe war die Adipozytengröße an Tag 105 der Laktation im SC 
Schwanzfett kleiner als an Tag 42. Die Adipozytengröße und das Depotgewicht 
korrelierten im SC Depot (r = 0,795, P < 0,01) in der CLA-Gruppe und im 
retroperitonealen Fett sowohl in der CON (r = 0,698, P < 0,01) als auch in der CLA (r = 
0,723, P < 0,05) Gruppe signifikant. Diese Langzeitstudie zeigt zum ersten Mal, dass 
CLA-Supplemente bei Milchkühen die Adipozytengröße von SC und VC Fettdepots in 
unterschiedlichem Ausmaß verringern können. Weiterhin weist die positive Korrelation 
zwischen Adipozytengröße und Plasma-BHBA darauf hin, dass die Lipolyse im AT 
sowohl in den CON als auch in den CLA-supplementierten Kühen depotspezifisch 
erhöht sein könnte. Die Ergebnisse lassen vermuten, dass CLA ähnlich wie bei 
Monogastern, lipolytische und/ oder antilipogene Effekte auf das bovine AT haben 
könnten. Es konnte jedoch lediglich eine geringe Infiltration phagozytierender 
Immunzellen in verschiedene Fettgewebe der frühlaktierenden Kühe nachgewiesen 
werden. In den wenigen positiven Proben war die Anzahl von ATM (CD68+) leicht, 
aber nicht signifikant höher in den VC als in den SC Fettdepots. Außerdem könnte die 
erhöhte Ansammlung phagozytierender Immmunzellen (unabhängig ihrer geringen 
Anzahl) im SC Fett nicht-tragender, überkonditionierter Färsen, mit der erhöhten 
Adipozytengröße und der damit einhergehenden erhöhten Sekretion von Chemokinen 
zusammenhängen. Der Körperfettgehalt bei Kühen in der Frühlaktation ist eventuell 
nicht hoch genug, um eine signifikante Infiltration phagozytierender Zellen zu 
bewirken. Daher sind diese Immunzellen in der immunologischen und metabolischen 
Anpassung bei Milchkühen während der Frühlaktation offenbar nicht von Bedeutung. 
CLA scheinen zudem keinen Effekt auf die Infiltration dieser Zellen in das bovine AT 
zu haben.  
Die Ergebnisse sind von allgemeiner Bedeutung für die Nutztierwissenschaften und 
liefern grundlegende Erkenntnisse für das Verständnis der Regulation des AT bei 
Wiederkäuern. Die hier vorliegende Dissertation trägt dazu bei, das Wissen über 
Langzeiteffekte von CLA-Supplementen auf die Körperfettdepots von Milchkühen zu 
verbessern. Um individuelle Effekte der c9,t11 und t10,c12 Isomere auf die 
Körperfettdepots von Milchkühen zu untersuchen, sind weitere Studien notwendig. Da 
CLA-Gaben die Differenzierung von bovinen Präadipozyten beeinflussen können, 
sollten weitere Studien zur Charakterisierung des bovinen AT im Zusammenhang mit 
Anzahl und Größe von Präadipozyten durchgeführt werden. Weiterhin wäre die 
Typisierung von ATM-Subpopulationen für die weitere Forschung wichtig. 
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